Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in JAMA

Retrieve available abstracts of 748 articles:
HTML format

Single Articles

    November 2022
    Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
    JAMA. 2022;328:2003.

    Targeted Flu Vaccination Campaigns Needed for Certain Racial and Ethnic Groups.
    JAMA. 2022;328:2005.

  3. YEK C, Kadri SS
    Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022;328:1977.

  4. FAUST JS, Renton B, Du C
    Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022;328:1977-1978.

    COVID-19 Limited Access to Sexual and Reproductive Health Services.
    JAMA. 2022;328:1896-1897.

    Second COVID-19 Booster Increases Protection for Nursing Home Patients.
    JAMA. 2022;328:1800-1801.

    October 2022
  7. BERNARD SA, Bray JE, Smith K, Stephenson M, et al
    Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial.
    JAMA. 2022 Oct 26. pii: 2798013. doi: 10.1001/jama.2022.17701.
    PubMed     Abstract available

  8. SURAN M
    VA Guidebook on Long COVID.
    JAMA. 2022;328:1580.

    Vitamin D Supplements Don't Reduce COVID-19 Risk.
    JAMA. 2022;328:1581.

  10. WALKER MD, Shane E
    Hypercalcemia: A Review.
    JAMA. 2022;328:1624-1636.
    PubMed     Abstract available

  11. FRIEDEN TR, McClelland A
    Preparing for Pandemics and Other Health Threats: Societal Approaches to Protect and Improve Health.
    JAMA. 2022;328:1585-1586.

  12. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2022 Oct 21. pii: 2797483. doi: 10.1001/jama.2022.18590.
    PubMed     Abstract available

  13. Interepidemic Influenza.
    JAMA. 2022;328:1566.

  14. JIANG Q, Zhang YF, Hu P
    Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
    JAMA. 2022;328:1561-1562.

  15. SHAVIT I, Koppel JH, Levy N
    Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel-Reply.
    JAMA. 2022;328:1562.

  16. THOMPSON MG, Yoon SK, Naleway AL, Meece J, et al
    Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
    JAMA. 2022;328:1523-1533.
    PubMed     Abstract available

    Estimate: 10.5 Million Children Lost a Parent, Caregiver to COVID-19.
    JAMA. 2022;328:1490.

  18. HSU CK, Lai CC
    Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant.
    JAMA. 2022;328:1460.

  19. DORABAWILA V, Bassett MT, Rosenberg ES
    Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant-Reply.
    JAMA. 2022;328:1460-1461.

  20. KUEHN BM
    Lowest US Life Expectancy Since 1996 Linked to COVID-19.
    JAMA. 2022;328:1389.

  21. WULF HANSON S, Abbafati C, Aerts JG, Al-Aly Z, et al
    Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    JAMA. 2022 Oct 10. pii: 2797443. doi: 10.1001/jama.2022.18931.
    PubMed     Abstract available

  22. ABBASI J
    White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations-Undercounted Deaths, Vaccine Inequity, and More.
    JAMA. 2022 Oct 5. pii: 2797281. doi: 10.1001/jama.2022.13663.

    Long COVID in Children.
    JAMA. 2022;328:1288.

    Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure.
    JAMA. 2022;328:1353-1354.

  25. RAGHUNATHAN K, Raghunathan A
    Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure.
    JAMA. 2022;328:1354.

  26. ALHAZZANI W, Weatherald J, Arabi YM
    Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure-Reply.
    JAMA. 2022;328:1354-1355.

    September 2022
    The COVID-19 Dashboard for Real-time Tracking of the Pandemic: The Lasker-Bloomberg Public Service Award.
    JAMA. 2022 Sep 28. pii: 2796722. doi: 10.1001/jama.2022.15590.

  28. NICHOL AD, O'Kane C, McAuley DF
    Respiratory Support in the Time of COVID-19.
    JAMA. 2022;328:1203-1205.

    Repurposed Drugs Failed to Prevent Severe COVID-19.
    JAMA. 2022;328:1171.

  30. FRAT JP, Quenot JP, Badie J, Coudroy R, et al
    Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial.
    JAMA. 2022;328:1212-1222.
    PubMed     Abstract available

  31. KUEHN BM
    Bus and Urban Transit Workers Have Highest COVID-19 Risk.
    JAMA. 2022;328:1173.

  32. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
    Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
    JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
    PubMed     Abstract available

  33. TENFORDE MW, Link-Gelles R, Patel MM
    Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
    JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.

  34. LIN DY, Gu Y, Xu Y, Wheeler B, et al
    Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
    JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
    PubMed     Abstract available

  35. RIDGWAY JP, Tideman S, French T, Wright B, et al
    Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose.
    JAMA. 2022 Sep 23. pii: 2796847. doi: 10.1001/jama.2022.17811.

  36. RUBIN R
    The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
    JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.

  37. ARABI YM, Aldekhyl S, Al Qahtani S, Al-Dorzi HM, et al
    Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial.
    JAMA. 2022;328:1063-1072.
    PubMed     Abstract available

    COVID-19 Health Policies and Economies in Nordic Countries.
    JAMA. 2022;328:1029.

  39. MATTA S, Nicholas LH
    Changes in Unemployment Among Health Care Workers Following the COVID-19 Pandemic.
    JAMA. 2022 Sep 19. pii: 2796661. doi: 10.1001/jama.2022.17608.

    New Data on Heterologous COVID-19 Vaccine Combinations.
    JAMA. 2022;328:916-917.

    Antibody Found in Mice Neutralizes SARS-CoV-2 and SARS-CoV-1.
    JAMA. 2022;328:916-917.

  42. KUEHN BM
    CDC Streamlines COVID-19 Guidance.
    JAMA. 2022;328:918-919.

  43. WEBBER C, Myran DT, Milani C, Turcotte L, et al
    Cognitive Decline in Long-term Care Residents Before and During the COVID-19 Pandemic in Ontario, Canada.
    JAMA. 2022 Sep 12. pii: 2796449. doi: 10.1001/jama.2022.17214.

  44. ABBASI J
    The US Now Has a Research Plan for Long COVID-Is It Enough?
    JAMA. 2022;328:812-814.

    August 2022
  45. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
    Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
    JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
    PubMed     Abstract available

    Self-sampling for SARS-CoV-2 Detection in Children.
    JAMA. 2022 Aug 26. pii: 2795838. doi: 10.1001/jama.2022.15225.

  47. WAGGONER JJ, Vos MB, Tyburski EA, Nguyen PV, et al
    Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
    JAMA. 2022 Aug 26. pii: 2795837. doi: 10.1001/jama.2022.14877.
    PubMed     Abstract available

    Study: New Wastewater Surveillance Method Detected SARS-CoV-2 Variants of Concern Up to 2 Weeks Before Clinical Tests.
    JAMA. 2022 Aug 24. pii: 2795815. doi: 10.1001/jama.2022.12563.

  49. RUBIN R
    Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
    JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.

  50. SURAN M
    Free COVID-19 Tests for People With Visual Impairment.
    JAMA. 2022;328:699.

    Antibody Testing's Limits for Detecting Prior SARS-CoV-2 Infection.
    JAMA. 2022;328:700-701.

  52. RUBIN R
    Pharmacists Allowed to Prescribe COVID-19 Antiviral.
    JAMA. 2022;328:612.

  53. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    PubMed     Abstract available

    Preventing COVID-19, Saving Lives in Lower-Income Countries.
    JAMA. 2022;328:611.

    New "Universal" Flu Vaccine Candidate Enters Clinical Trial.
    JAMA. 2022;328:518.

  56. KUEHN BM
    More Effective Flu Vaccines Recommended for Older Adults.
    JAMA. 2022;328:519.

  57. KUEHN BM
    Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
    JAMA. 2022;328:519.

  58. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
    JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.

    Animal Reservoirs-Where the Next SARS-CoV-2 Variant Could Arise.
    JAMA. 2022 Aug 3. pii: 2795140. doi: 10.1001/jama.2022.9789.

    Addressing the Long-term Effects of COVID-19.
    JAMA. 2022 Aug 3. pii: 2795139. doi: 10.1001/jama.2022.14089.

    Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.
    JAMA. 2022;328:415.

    Maternal Death Rate Increased During Early COVID-19 Pandemic.
    JAMA. 2022;328:415.

  63. GENZEN JR, Rychert J, George TI
    Integrity of SARS-CoV-2 Laboratory-Developed Tests.
    JAMA. 2022;328:478.

  64. ADASHI EY, Cohen G
    Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.
    JAMA. 2022;328:478-479.

  65. BIRNIE E, Biemond JJ, Appelman B, de Bree GJ, et al
    Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
    JAMA. 2022 Aug 1. pii: 2794999. doi: 10.1001/jama.2022.13854.

    July 2022
  66. VASAN A, Foote M, Long T
    Ensuring Widespread and Equitable Access to Treatments for COVID-19.
    JAMA. 2022 Jul 29. pii: 2794967. doi: 10.1001/jama.2022.13554.

  67. ZENG G
    SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
    JAMA. 2022;328:395.

  68. ULLOA AC, Buchan SA, Brown KA
    SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.
    JAMA. 2022;328:395-396.

    Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.
    JAMA. 2022;328:322.

  70. KUEHN BM
    Persistent Disparities in COVID-19 Antiviral Dispensing.
    JAMA. 2022;328:323.

  71. MALANI AG, Malani AN
    Preventive Medication for COVID-19 Infection.
    JAMA. 2022 Jul 25. pii: 2794799. doi: 10.1001/jama.2022.13214.

  72. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.

  73. WEBER E, Van Buren N, Cunningham T
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
    JAMA. 2022;328:301-302.

  74. LIN HY, Chen MH, Liang CS
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
    JAMA. 2022;328:301.

  75. KENIK J
    Remote Patient Monitoring During COVID-19.
    JAMA. 2022;328:302-303.

  76. AZOULAY E, Pochard F, Kentish-Barnes N
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge-Reply.
    JAMA. 2022;328:302.

  77. PRONOVOST PJ, Cole MD, Hughes RM
    Remote Patient Monitoring During COVID-19-Reply.
    JAMA. 2022;328:303-304.

    Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
    JAMA. 2022;328:234.

  79. RUBIN R
    COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
    JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.

  80. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
    Changes in the Relationship Between Income and Life Expectancy Before and During the COVID-19 Pandemic, California, 2015-2021.
    JAMA. 2022 Jul 7. pii: 2794146. doi: 10.1001/jama.2022.10952.
    PubMed     Abstract available

    First Nonprescription COVID-19 Test That Also Detects Flu and RSV.
    JAMA. 2022;328:11.

    Expiration Dates Extended on COVID-19 Monoclonal Antibody Therapies.
    JAMA. 2022;328:11.

  83. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
    Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
    JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.

    June 2022
  84. RUDYM D, Chang SH, Angel LF
    Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant.
    JAMA. 2022;327:2454.

  85. MANERIKAR A, Budinger GRS, Bharat A
    Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant-Reply.
    JAMA. 2022;327:2454-2455.

  86. CARDOSO CC, Rossi AD, Galliez RM, Faffe DS, et al
    Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil.
    JAMA. 2022 Jun 24. pii: 2793811. doi: 10.1001/jama.2022.11006.

  87. ABBASI J
    COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.

  88. RUBIN R
    Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.
    JAMA. 2022;327:2281.

    mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    JAMA. 2022;327:2280.

  90. HAMAD R, Galea S
    The Role of Health Care Systems in Bolstering the Social Safety Net to Address Health Inequities in the Wake of the COVID-19 Pandemic.
    JAMA. 2022 Jun 15. pii: 2793581. doi: 10.1001/jama.2022.10160.

  91. KLOMPAS M, Pandolfi MC, Nisar AB, Baker MA, et al
    Association of Omicron vs Wild-type SARS-CoV-2 Variants With Hospital-Onset SARS-CoV-2 Infections in a US Regional Hospital System.
    JAMA. 2022 Jun 15. pii: 2793582. doi: 10.1001/jama.2022.9609.

    Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
    JAMA. 2022;327:2182.

    Urine Test Detects SARS-CoV-2 Antibodies.
    JAMA. 2022;327:2182.

    COVID-19 Treatments for Nonhospitalized Patients.
    JAMA. 2022;327:2247.

    COVID-19 Treatments for Nonhospitalized Patients.
    JAMA. 2022;327:2248.

  96. GANDHI RT, Malani PN, Del Rio C
    COVID-19 Treatments for Nonhospitalized Patients-Reply.
    JAMA. 2022;327:2248.

  97. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.

  98. JONES JM, Opsomer JD, Stone M, Benoit T, et al
    Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
    JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.

  99. RUBIN R
    From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid.
    JAMA. 2022 Jun 8. pii: 2793357. doi: 10.1001/jama.2022.9925.

  100. LARKIN HD
    Warning Against Counterfeit At-home COVID-19 Tests.
    JAMA. 2022;327:2067.

  101. LI Y
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
    JAMA. 2022;327:2147-2148.

  102. LATRONICO N, Rasulo FA, Piva S
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2149.

  103. BAI W, Jackson T, Xiang YT
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2148-2149.

  104. SEVIN CM, Ely EW
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2149-2150.

  105. MASLO C, Toubkin M
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave-Reply.
    JAMA. 2022;327:2148.

  106. HEESAKKERS H, van den Boogaard M, Zegers M
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19-Reply.
    JAMA. 2022;327:2150-2151.

  107. VIJAY A, Yancy CW
    Resident Physician Wellness Postpandemic: How Does Healing Occur?
    JAMA. 2022;327:2077-2078.

  108. DOWELL D, Lindsley WG, Brooks JT
    Reducing SARS-CoV-2 in Shared Indoor Air.
    JAMA. 2022 Jun 7. pii: 2793289. doi: 10.1001/jama.2022.9970.

  109. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.

  110. RUBIN R
    Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
    JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.

    May 2022
  111. DEL RIO C, Malani PN
    COVID-19 in 2022-The Beginning of the End or the End of the Beginning?
    JAMA. 2022 May 27. pii: 2793011. doi: 10.1001/jama.2022.9655.

  112. WEISS SR
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    JAMA. 2022;327:2019-2020.

  113. PEREZ-FERNANDEZ XL, Fuset-Cabanes M, Hernandez-Platero L
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
    JAMA. 2022;327:2022-2023.

  114. YARNELL CJ, Sklar MC
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
    JAMA. 2022;327:2023.

  115. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.

  116. COUPER K, Connolly BA, McAuley DF
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19-Reply.
    JAMA. 2022;327:2023-2024.

  117. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.

  118. FAUST JS, Du C, Liang C, Mayes KD, et al
    Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022 May 20. pii: 2792738. doi: 10.1001/jama.2022.8045.

  119. LEVY N, Koppel JH, Kaplan O, Yechiam H, et al
    Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
    JAMA. 2022 May 19. pii: 2792718. doi: 10.1001/jama.2022.8025.

  120. RUBIN R
    SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus.
    JAMA. 2022 May 18. pii: 2792688. doi: 10.1001/jama.2022.7892.

  121. BELLANDI D, Voelker R
    New White House COVID-19 Leader on What's Next.
    JAMA. 2022 May 18. pii: 2792686. doi: 10.1001/jama.2022.8541.

  122. RUBIN R
    First Breathalyzer Test to Diagnose COVID-19.
    JAMA. 2022;327:1860.

    Rapid Antigen Tests for SARS-CoV-2.
    JAMA. 2022;327:1925-1926.

  124. GANS JS, Goldfarb A, Rosella L
    Rapid Antigen Tests for SARS-CoV-2-Reply.
    JAMA. 2022;327:1926.

    The Pandemic Determinants of Health.
    JAMA. 2022;327:1869.

  126. ALHAZZANI W, Parhar KKS, Weatherald J, Al Duhailib Z, et al
    Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.
    JAMA. 2022 May 15. pii: 2792506. doi: 10.1001/jama.2022.7993.
    PubMed     Abstract available

  127. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
    Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
    PubMed     Abstract available

  128. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.

  129. HOURY DE, Simon TR, Crosby AE
    Firearm Homicide and Suicide During the COVID-19 Pandemic: Implications for Clinicians and Health Care Systems.
    JAMA. 2022 May 10. pii: 2792080. doi: 10.1001/jama.2022.6924.

  130. LARKIN HD
    Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
    JAMA. 2022;327:1748.

  131. LARKIN HD
    Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
    JAMA. 2022;327:1748.

  132. MANGURIAN C, Fitelson EM, Epel E
    COVID-19 and Lessons to Improve Preparedness for the Next Pandemic.
    JAMA. 2022;327:1822-1823.

  133. CHEN J, Al-Azzawi ZAM, Taifour T
    Testing, Surveillance, and Mitigation Strategies for COVID-19.
    JAMA. 2022;327:1824-1825.

    Strategy for the "New Normal" of Life With COVID.
    JAMA. 2022;327:1823-1824.

  135. NUZZO JB, Gostin LO
    COVID-19 and Lessons to Improve Preparedness for the Next Pandemic-Reply.
    JAMA. 2022;327:1823.

  136. EMANUEL EJ, Michaels D, Bright RA
    Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply.
    JAMA. 2022;327:1825.

  137. EMANUEL EJ, Osterholm M, Gounder CR
    Strategy for the "New Normal" of Life With COVID-Reply.
    JAMA. 2022;327:1824.

  138. KUEHN BM
    mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
    JAMA. 2022;327:1749.

  139. SLOMSKI A
    Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
    JAMA. 2022;327:1641.

  140. MARKS P, Woodcock J, Califf R
    COVID-19 Vaccination-Becoming Part of the New Normal.
    JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.

  141. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al
    Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
    JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
    PubMed     Abstract available

    April 2022
  142. RUBIN R
    The COVID-19 Pandemic Rages on for People Who Are Immunocompromised.
    JAMA. 2022 Apr 27. pii: 2791868. doi: 10.1001/jama.2022.7281.

  143. SURAN M
    White Individuals Experience Less COVID-19-Related Discrimination.
    JAMA. 2022;327:1538.

  144. KUEHN BM
    COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
    JAMA. 2022;327:1540.

  145. SLOMSKI A
    Long-Acting RSV Antibody Injection Protects Healthy Infants.
    JAMA. 2022;327:1539.

  146. PETTY LA, Malani PN
    Oral Antiviral Medications for COVID-19.
    JAMA. 2022 Apr 25. pii: 2791780. doi: 10.1001/jama.2022.6876.

  147. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
    Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
    JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.

  148. SURAN M
    Stagnant US Mammography Rates and the Influence of COVID-19.
    JAMA. 2022 Apr 20. pii: 2791573. doi: 10.1001/jama.2022.4295.

  149. LARKIN HD
    Global COVID-19 Death Toll May Be Triple the Reported Deaths.
    JAMA. 2022;327:1438.

  150. LARKIN HD
    WHO Urges Monitoring SARS-CoV-2 in Wildlife to Prevent Animal Reservoirs.
    JAMA. 2022;327:1438.

  151. LARKIN HD
    Fractionating COVID-19 Vaccine Doses May Save Lives.
    JAMA. 2022;327:1438.

  152. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.

  153. ABBASI J
    Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    JAMA. 2022;327:1323.

  154. KUEHN BM
    Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
    JAMA. 2022;327:1324.

  155. ABBASI J
    Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
    JAMA. 2022;327:1323.

  156. TSAY SV, Bartoces M, Gouin K, Kabbani S, et al
    Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021.
    JAMA. 2022 Apr 8. pii: 2791077. doi: 10.1001/jama.2022.5471.

  157. BRADLEY MC, Perez-Vilar S, Chillarige Y, Dong D, et al
    Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.
    JAMA. 2022 Apr 8. pii: 2791078. doi: 10.1001/jama.2022.4877.

  158. SLOMSKI A
    At-home COVID-19 Test Instructions Frequently Misinterpreted.
    JAMA. 2022;327:1218.

  159. SLOMSKI A
    Maternal COVID-19 Vaccine Safe for Infants.
    JAMA. 2022;327:1218.

  160. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
    Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
    PubMed     Abstract available

  161. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
    Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
    JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.

    March 2022
  162. SAGE WM, Yang YT
    Reducing "COVID-19 Misinformation" While Preserving Free Speech.
    JAMA. 2022 Mar 31. pii: 2790859. doi: 10.1001/jama.2022.4231.

  163. KHARBANDA EO, Vazquez-Benitez G
    COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
    JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.

  164. ADHIKARI EH, MacDonald L, SoRelle JA, Morse J, et al
    COVID-19 Cases and Disease Severity in Pregnancy and Neonatal Positivity Associated With Delta (B.1.617.2) and Omicron (B.1.1.529) Variant Predominance.
    JAMA. 2022 Mar 24. pii: 2790609. doi: 10.1001/jama.2022.4356.

  165. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
    Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
    PubMed     Abstract available

  166. FELL DB, Dhinsa T, Alton GD, Torok E, et al
    Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
    JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
    PubMed     Abstract available

  167. ABBASI J
    Even Mild COVID-19 May Change the Brain.
    JAMA. 2022 Mar 23. pii: 2790595. doi: 10.1001/jama.2022.4507.

  168. BRADBURY CA, Lawler PR, Stanworth SJ, McVerry BJ, et al
    Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2022 Mar 22. pii: 2790488. doi: 10.1001/jama.2022.2910.
    PubMed     Abstract available

  169. CONNORS JM, Ridker PM
    Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status.
    JAMA. 2022 Mar 22. pii: 2790489. doi: 10.1001/jama.2022.2361.

  170. WHITE AM, Castle IP, Powell PA, Hingson RW, et al
    Alcohol-Related Deaths During the COVID-19 Pandemic.
    JAMA. 2022 Mar 18. pii: 2790491. doi: 10.1001/jama.2022.4308.

  171. LIEBOWITZ JE, Konig MF
    Joint Pain in a Woman Wearing a Face Mask.
    JAMA. 2022 Mar 17. pii: 2790422. doi: 10.1001/jama.2022.2644.

  172. LI J, Pavlov I, Ehrmann S
    High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19.
    JAMA. 2022;327:1092.

  173. OSPINA-TASCON GA, Martinez D, Gempeler A
    High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19-Reply.
    JAMA. 2022;327:1092-1093.

  174. GUPTA A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al
    Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2022 Mar 14. pii: 2790246. doi: 10.1001/jama.2022.2832.
    PubMed     Abstract available

  175. COREY L, Corbett-Detig R, Beyrer C
    Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics.
    JAMA. 2022 Mar 11. pii: 2790239. doi: 10.1001/jama.2022.3517.

  176. RUBIN R
    Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor.
    JAMA. 2022 Mar 9. pii: 2790074. doi: 10.1001/jama.2022.3214.

  177. JORGENSEN SB, Nygard K, Kacelnik O, Telle K, et al
    Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households.
    JAMA. 2022 Mar 7. pii: 2789920. doi: 10.1001/jama.2022.3780.

  178. ADASHI EY, Cohen IG
    SARS-CoV-2 Laboratory-Developed Tests: Integrity Restored.
    JAMA. 2022 Mar 4. pii: 2789917. doi: 10.1001/jama.2022.3382.

  179. TONELLI M, Warick R
    Focusing on the Needs of People With Hearing Loss During the COVID-19 Pandemic and Beyond.
    JAMA. 2022 Mar 3. pii: 2789772. doi: 10.1001/jama.2022.3026.

  180. ABBASI J
    The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
    JAMA. 2022 Mar 2. pii: 2789793. doi: 10.1001/jama.2022.2411.

  181. GOMES T, Campbell TJ, Kitchen SA, Garg R, et al
    Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
    JAMA. 2022;327:846-855.
    PubMed     Abstract available

  182. BROOKS MM, Wisniewski SR
    Assessing Unexpected Circumstances That Lead to Modifications in Clinical Trial Design, Conduct, or Analysis: Application of the CONSERVE Reporting Guideline.
    JAMA. 2022;327:868-869.

  183. SLOMSKI A
    Metabolic Surgery Associated With Less Severe COVID-19.
    JAMA. 2022;327:804.

    February 2022
  184. PRONOVOST PJ, Cole MD, Hughes RM
    Remote Patient Monitoring During COVID-19: An Unexpected Patient Safety Benefit.
    JAMA. 2022 Feb 25. pii: 2789635. doi: 10.1001/jama.2022.2040.

  185. AZOULAY E, Resche-Rigon M, Megarbane B, Reuter D, et al
    Association of COVID-19 Acute Respiratory Distress Syndrome With Symptoms of Posttraumatic Stress Disorder in Family Members After ICU Discharge.
    JAMA. 2022 Feb 18. pii: 2789436. doi: 10.1001/jama.2022.2017.
    PubMed     Abstract available

  186. ULLOA AC, Buchan SA, Daneman N, Brown KA, et al
    Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
    JAMA. 2022 Feb 17. pii: 2789408. doi: 10.1001/jama.2022.2274.

  187. RUBIN R
    When Physicians Spread Unscientific Information About COVID-19.
    JAMA. 2022 Feb 16. pii: 2789369. doi: 10.1001/jama.2022.1083.

  188. ZHENG H, Bu S
    Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia.
    JAMA. 2022;327:682.

  189. ZHAO B, Ma W
    Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia.
    JAMA. 2022;327:682.

  190. ABOUIR K, Calmy A, Lorenzini KRI
    Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia.
    JAMA. 2022;327:682-683.

  191. MUNCH MW, Granholm A, Perner A
    Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia-Reply.
    JAMA. 2022;327:683.

  192. MORRISON RS, Meier DE, Arnold RM
    Controversies About Advance Care Planning-Reply.
    JAMA. 2022;327:686.

  193. BRITTON A, Fleming-Dutra KE, Shang N, Smith ZR, et al
    Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
    JAMA. 2022 Feb 14. pii: 2789294. doi: 10.1001/jama.2022.2068.
    PubMed     Abstract available

  194. TAN SHX, Pung R, Wang LF, Lye DC, et al
    Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
    JAMA. 2022 Feb 11. pii: 2789151. doi: 10.1001/jama.2022.1922.

  195. SURAN M
    How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic.
    JAMA. 2022 Feb 9. pii: 2789055. doi: 10.1001/jama.2022.1510.

  196. MINKOFF HL, Ecker JL
    Prenatal Cannabis Use Before and During the COVID-19 Pandemic.
    JAMA. 2022;327:587.

  197. YOUNG-WOLFF KC, Ansley D, Avalos LA
    Prenatal Cannabis Use Before and During the COVID-19 Pandemic-Reply.
    JAMA. 2022;327:587-588.

  198. METZ TD, Clifton RG, Hughes BL, Sandoval GJ, et al
    Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications.
    JAMA. 2022 Feb 7. pii: 2788985. doi: 10.1001/jama.2022.1190.
    PubMed     Abstract available

  199. SHOOK LL, Atyeo CG, Yonker LM, Fasano A, et al
    Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
    JAMA. 2022 Feb 7. pii: 2788986. doi: 10.1001/jama.2022.1206.

  200. BEHR CL, Joynt Maddox KE, Meara E, Epstein AM, et al
    Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021.
    JAMA. 2022 Feb 4. pii: 2788904. doi: 10.1001/jama.2022.1243.

  201. AKASHI H, Shimada S, Tamura T, Chinda E, et al
    SARS-CoV-2 Infections in Close Contacts of Positive Cases in the Olympic and Paralympic Village at the 2021 Tokyo Olympic and Paralympic Games.
    JAMA. 2022 Feb 3. pii: 2788895. doi: 10.1001/jama.2022.0818.

  202. ALEJO JL, Mitchell J, Chang A, Chiang TPY, et al
    Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19.
    JAMA. 2022 Feb 3. pii: 2788894. doi: 10.1001/jama.2022.1393.

  203. SURAN M
    Preparing Hospitals' Medical Oxygen Delivery Systems for a Respiratory "Twindemic".
    JAMA. 2022;327:411-413.

    January 2022
  204. SARZYNSKI SH, Mancera A, Mann C, Dai M, et al
    Frequency and Risk of Emergency Medical Service Interhospital Transportation of Patients With Acute Lower Respiratory Tract Illness During the COVID-19 Pandemic in the US.
    JAMA. 2022 Jan 28. pii: 2788712. doi: 10.1001/jama.2022.0812.

  205. KURIHARA C, Manerikar A, Querrey M, Felicelli C, et al
    Clinical Characteristics and Outcomes of Patients With COVID-19-Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant.
    JAMA. 2022 Jan 27. pii: 2788640. doi: 10.1001/jama.2022.0204.
    PubMed     Abstract available

  206. LUO Y, Wunderink RG, Lloyd-Jones D
    Proactive vs Reactive Machine Learning in Health Care: Lessons From the COVID-19 Pandemic.
    JAMA. 2022 Jan 27. pii: 2788639. doi: 10.1001/jama.2021.24935.

  207. ABBASI J
    COVID-19 and the Common Cold-Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity.
    JAMA. 2022 Jan 26. pii: 2788621. doi: 10.1001/jama.2022.0326.

  208. LI HF, Hu SM, Lv M
    Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome.
    JAMA. 2022;327:392-393.

  209. WOO EJ, Dimova RB, Mba-Jonas A
    Presumptive Guillain-Barre Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.
    JAMA. 2022;327:393-394.

  210. KUEHN BM
    Fall Influenza A(H3N2) Outbreak at a Midwestern University.
    JAMA. 2022;327:315.

  211. ZAMPIERI FG, Ferreira JC
    Defining Optimal Respiratory Support for Patients With COVID-19.
    JAMA. 2022 Jan 24. pii: 2788506. doi: 10.1001/jama.2022.0067.

  212. HEESAKKERS H, van der Hoeven JG, Corsten S, Janssen I, et al
    Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022 Jan 24. pii: 2788504. doi: 10.1001/jama.2022.0040.
    PubMed     Abstract available

  213. PERKINS GD, Ji C, Connolly BA, Couper K, et al
    Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
    JAMA. 2022 Jan 24. pii: 2788505. doi: 10.1001/jama.2022.0028.
    PubMed     Abstract available

  214. KLOMPAS M, Karan A
    Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant.
    JAMA. 2022 Jan 24. pii: 2788503. doi: 10.1001/jama.2022.0262.

  215. OMER SB, Malani PN
    Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.
    JAMA. 2022 Jan 21. pii: 2788487. doi: 10.1001/jama.2022.0892.

  216. ACCORSI EK, Britton A, Fleming-Dutra KE, Smith ZR, et al
    Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    JAMA. 2022 Jan 21. pii: 2788485. doi: 10.1001/jama.2022.0470.
    PubMed     Abstract available

  217. ABBASI J, Rubin R, Suran M
    How the Supreme Court's COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic's Next Phase.
    JAMA. 2022 Jan 21. pii: 2788486. doi: 10.1001/jama.2022.0791.

  218. GOSTIN LO, Parmet WE, Rosenbaum S
    The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.
    JAMA. 2022 Jan 21. pii: 2788481. doi: 10.1001/jama.2022.0852.

  219. WANG L, Davis PB, Kaelber DC, Volkow ND, et al
    Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
    JAMA. 2022 Jan 20. pii: 2788408. doi: 10.1001/jama.2022.0210.

  220. SPAETGENS B, Nagy M, Ten Cate H
    Antiplatelet Therapy in Patients With COVID-19-More Is Less?
    JAMA. 2022;327:223-224.

  221. BERGER JS, Kornblith LZ, Gong MN, Reynolds HR, et al
    Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2022;327:227-236.
    PubMed     Abstract available

  222. MAFI JN, Craff M, Vangala S, Pu T, et al
    Trends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021.
    JAMA. 2022;327:237-247.
    PubMed     Abstract available

  223. EMANUEL EJ, Osterholm M, Gounder CR
    A National Strategy for the "New Normal" of Life With COVID.
    JAMA. 2022;327:211-212.

  224. ABBASI J
    Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19.
    JAMA. 2022 Jan 18. pii: 2788316. doi: 10.1001/jama.2022.0216.

  225. LI JZ, Gandhi RT
    Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management.
    JAMA. 2022 Jan 14. pii: 2788257. doi: 10.1001/jama.2021.19994.

  226. O'BRIEN MP, Forleo-Neto E, Sarkar N, Isa F, et al
    Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
    JAMA. 2022 Jan 14. pii: 2788256. doi: 10.1001/jama.2021.24939.
    PubMed     Abstract available

  227. GANDHI RT, Malani PN, Del Rio C
    COVID-19 Therapeutics for Nonhospitalized Patients.
    JAMA. 2022 Jan 14. pii: 2788254. doi: 10.1001/jama.2022.0335.

  228. CHUA KP, Conti RM, Becker NV
    US Insurer Spending on Ivermectin Prescriptions for COVID-19.
    JAMA. 2022 Jan 13. pii: 2788253. doi: 10.1001/jama.2021.24352.

  229. ABBASI J
    Studies Suggest COVID-19 Vaccine Boosters Save Lives.
    JAMA. 2022;327:115.

  230. ABBASI J
    Homing In On a SARS-CoV-2 Correlate of Protection.
    JAMA. 2022;327:115.

  231. ABBASI J
    COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
    JAMA. 2022;327:115.

  232. WYLLIE AL, Premsrirut PK
    Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection.
    JAMA. 2022;327:182-183.

  233. PANNARAJ PS, Congrave-Wilson Z, Lee Y
    Saliva RT-PCR Sensitivity Over the Course of SARS-COV-2 Infection-Reply.
    JAMA. 2022;327:183-184.

  234. RUBIN R
    COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?
    JAMA. 2022 Jan 11. pii: 2788213. doi: 10.1001/jama.2022.0106.

  235. WALD A
    Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.
    JAMA. 2022 Jan 10. pii: 2788105. doi: 10.1001/jama.2021.23726.

  236. SPITZER A, Angel Y, Marudi O, Zeltser D, et al
    Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    JAMA. 2022 Jan 10. pii: 2788104. doi: 10.1001/jama.2021.23641.
    PubMed     Abstract available

  237. GANS JS, Goldfarb A, Agrawal AK, Sennik S, et al
    False-Positive Results in Rapid Antigen Tests for SARS-CoV-2.
    JAMA. 2022 Jan 7. pii: 2788067. doi: 10.1001/jama.2021.24355.

  238. MICHAELS D, Emanuel EJ, Bright RA
    A National Strategy for COVID-19: Testing, Surveillance, and Mitigation Strategies.
    JAMA. 2022 Jan 6. pii: 2787945. doi: 10.1001/jama.2021.24168.

  239. BORIO LL, Bright RA, Emanuel EJ
    A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    JAMA. 2022 Jan 6. pii: 2787946. doi: 10.1001/jama.2021.24165.

  240. NUZZO JB, Gostin LO
    The First 2 Years of COVID-19: Lessons to Improve Preparedness for the Next Pandemic.
    JAMA. 2022 Jan 6. pii: 2787943. doi: 10.1001/jama.2021.24394.

  241. PARK JJH, Detry MA, Murthy S, Guyatt G, et al
    How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature.
    JAMA. 2022;327:67-74.
    PubMed     Abstract available

  242. RUDD KE, Mair CF, Angus DC
    Applying Syndemic Theory to Acute Illness.
    JAMA. 2022;327:33-34.

    December 2021
  243. OKIKE K, Chan PH, Navarro RA, Khatod MX, et al
    Hip Fracture Surgery Volumes Among Individuals 65 Years and Older During the COVID-19 Pandemic.
    JAMA. 2021 Dec 30. pii: 2787777. doi: 10.1001/jama.2021.23761.

  244. MASLO C, Friedland R, Toubkin M, Laubscher A, et al
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.
    JAMA. 2021 Dec 30. pii: 2787776. doi: 10.1001/jama.2021.24868.

  245. RUBIN R
    Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis.
    JAMA. 2021 Dec 29. pii: 2787758. doi: 10.1001/jama.2021.23557.

  246. ABBASI J
    RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
    JAMA. 2021 Dec 29. pii: 2787757. doi: 10.1001/jama.2021.23772.

  247. SLOMSKI A
    More Pediatric Data for First Cell-Derived Influenza Vaccine.
    JAMA. 2021;326:2464.

  248. KUEHN BM
    Influenza Vaccination Increased During the COVID-19 Pandemic.
    JAMA. 2021;326:2465.

  249. ABBASI J
    Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
    JAMA. 2021;326:2460-2462.

  250. RUBIN R
    Expanding Access to Medication Abortions.
    JAMA. 2021 Dec 22. pii: 2787610. doi: 10.1001/jama.2021.23357.

  251. DEL RIO C, Omer SB, Malani PN
    Winter of Omicron-The Evolving COVID-19 Pandemic.
    JAMA. 2021 Dec 22. pii: 2787609. doi: 10.1001/jama.2021.24315.

  252. COHN AC, Mahon BE, Walensky RP
    One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality.
    JAMA. 2021 Dec 21. pii: 2787504. doi: 10.1001/jama.2021.23962.

  253. CAMBRA-BADII I, Guardiola E, Banos JE
    The COVID-19 Pandemic in Serial Medical Dramas.
    JAMA. 2021 Dec 20. pii: 2787497. doi: 10.1001/jama.2021.19779.

  254. LEVY M, Recher M, Hubert H, Javouhey E, et al
    Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.
    JAMA. 2021 Dec 20. pii: 2787495. doi: 10.1001/jama.2021.23262.

  255. MACLAREN G, Fisher D, Brodie D
    Treating the Most Critically Ill Patients With COVID-19: The Evolving Role of Extracorporeal Membrane Oxygenation.
    JAMA. 2021 Dec 17. pii: 2787451. doi: 10.1001/jama.2021.22580.

  256. BATES TA, McBride SK, Winders B, Schoen D, et al
    Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
    JAMA. 2021 Dec 16. pii: 2787447. doi: 10.1001/jama.2021.22898.

  257. SURAN M
    Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
    JAMA. 2021 Dec 15. pii: 2787289. doi: 10.1001/jama.2021.21625.

  258. ABBASI J
    Immunocompromised Patients With COVID-19 Receive Interferon Gamma.
    JAMA. 2021;326:2250.

  259. WALTER K
    COVID-19 and Pregnancy.
    JAMA. 2021 Dec 10. pii: 2787240. doi: 10.1001/jama.2021.22679.

  260. OSPINA-TASCON GA, Calderon-Tapia LE, Garcia AF, Zarama V, et al
    Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial.
    JAMA. 2021;326:2161-2171.
    PubMed     Abstract available

  261. ABBASI J
    Data Emerge From the UK's COVID-19 Vaccine Extended Dosing Interval.
    JAMA. 2021 Dec 3. pii: 2786993. doi: 10.1001/jama.2021.21963.

    November 2021
  262. RUBIN R
    COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
    JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.

  263. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.

  264. SLOMSKI A
    Thousands of US Youths Cope With the Trauma of Losing Parents to COVID-19.
    JAMA. 2021 Nov 17. pii: 2786533. doi: 10.1001/jama.2021.20846.

  265. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.

  266. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.

  267. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
    Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
    JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.

  268. KLOMPAS M
    Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
    JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.

  269. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
    Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
    PubMed     Abstract available

  270. SLOMSKI A
    Trials Test Mushrooms and Herbs as Anti-COVID-19 Agents.
    JAMA. 2021 Nov 3. pii: 2786023. doi: 10.1001/jama.2021.19388.

  271. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed     Abstract available

  272. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
    Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
    JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.

    October 2021
  273. FANAROFF AC, Garcia S, Giri J
    Myocardial Infarction During the COVID-19 Pandemic.
    JAMA. 2021 Oct 29. pii: 2785894. doi: 10.1001/jama.2021.19608.

  274. SAAD M, Kennedy KF, Imran H, Louis DW, et al
    Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.
    JAMA. 2021 Oct 29. pii: 2785893. doi: 10.1001/jama.2021.18890.
    PubMed     Abstract available

  275. GRAVES JA, Baig K, Buntin M
    The Financial Effects and Consequences of COVID-19: A Gathering Storm.
    JAMA. 2021 Oct 29. pii: 2785892. doi: 10.1001/jama.2021.18863.

  276. RUBIN R
    Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis Can't Come Fast Enough for Some People.
    JAMA. 2021 Oct 27. pii: 2785781. doi: 10.1001/jama.2021.19534.

  277. GOSTIN LO, Nuzzo JB
    Twenty Years After the Anthrax Terrorist Attacks of 2001: Lessons Learned and Unlearned for the COVID-19 Response.
    JAMA. 2021 Oct 27. pii: 2785780. doi: 10.1001/jama.2021.19292.

  278. WEBB SA, Higgins AM, McArthur CJ
    Glucocorticoid Dose in COVID-19: Lessons for Clinical Trials During a Pandemic.
    JAMA. 2021 Oct 21. pii: 2785531. doi: 10.1001/jama.2021.16438.

  279. MUNCH MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, et al
    Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
    JAMA. 2021 Oct 21. pii: 2785529. doi: 10.1001/jama.2021.18295.
    PubMed     Abstract available

  280. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.

  281. PEREZ A
    The Other Side.
    JAMA. 2021;326:1479-1480.

  282. KUEHN BM
    COVID-19 Precautions Help Make Music That's Beautiful and Safe.
    JAMA. 2021 Oct 14. pii: 2785304. doi: 10.1001/jama.2021.17558.

  283. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.

  284. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.

  285. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.

  286. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.

    Antithrombotic Therapy for Outpatients With COVID-19: Implications for Clinical Practice and Future Research.
    JAMA. 2021 Oct 11. pii: 2785220. doi: 10.1001/jama.2021.17460.

  288. CONNORS JM, Brooks MM, Sciurba FC, Krishnan JA, et al
    Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial.
    JAMA. 2021 Oct 11. pii: 2785218. doi: 10.1001/jama.2021.17272.
    PubMed     Abstract available

  289. DALLE AVE AL, Sulmasy DP
    Health Care Professionals' Spirituality and COVID-19: Meaning, Compassion, Relationship.
    JAMA. 2021 Oct 8. pii: 2785147. doi: 10.1001/jama.2021.16769.

  290. ABBASI J
    COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes.
    JAMA. 2021 Oct 6. pii: 2784943. doi: 10.1001/jama.2021.13326.

  291. MARQUEZ N, Ward JA, Parish K, Saloner B, et al
    COVID-19 Incidence and Mortality in Federal and State Prisons Compared With the US Population, April 5, 2020, to April 3, 2021.
    JAMA. 2021 Oct 6. pii: 2784944. doi: 10.1001/jama.2021.17575.

  292. SLOMSKI A
    Pediatric Depression and Anxiety Doubled During the Pandemic.
    JAMA. 2021;326:1246.

  293. GOSTIN LO, Halabi SF, Klock KA
    An International Agreement on Pandemic Prevention and Preparedness.
    JAMA. 2021;326:1257-1258.

  294. BLINKEN AJ, Becerra X
    Strengthening Global Health Security and Reforming the International Health Regulations: Making the World Safer From Future Pandemics.
    JAMA. 2021;326:1255-1256.

  295. VEST JR, Blackburn J, Cash-Goldwasser S, Peters Bergquist E, et al
    Mask-Wearing Behavior at the 2021 NCAA Men's Basketball Tournament.
    JAMA. 2021;326:1324-1325.

  296. ESTCOURT LJ, Turgeon AF, McQuilten ZK, McVerry BJ, et al
    Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2021 Oct 4. pii: 2784914. doi: 10.1001/jama.2021.18178.
    PubMed     Abstract available

    September 2021
  297. YOUNG-WOLFF KC, Ray GT, Alexeeff SE, Adams SR, et al
    Rates of Prenatal Cannabis Use Among Pregnant Women Before and During the COVID-19 Pandemic.
    JAMA. 2021 Sep 27. pii: 2784637. doi: 10.1001/jama.2021.16328.

  298. RUBIN R
    COVID-19 Testing Moves Out of the Clinic and Into the Home.
    JAMA. 2021 Sep 22. pii: 2784554. doi: 10.1001/jama.2021.15679.

  299. KERLIN MP
    It Is What It Is.
    JAMA. 2021;326:1007-1008.

  300. NEPRASH HT, Chernew ME
    Physician Practice Interruptions in the Treatment of Medicare Patients During the COVID-19 Pandemic.
    JAMA. 2021 Sep 20. pii: 2784484. doi: 10.1001/jama.2021.16324.

  301. COFFEY KC, Diekema DJ, Morgan DJ
    Interpreting SARS-CoV-2 Test Results.
    JAMA. 2021 Sep 17. pii: 2784473. doi: 10.1001/jama.2021.16146.

  302. RUBIN R
    How COVID-19 Made It Even Tougher to Know ICU Patients as Individuals.
    JAMA. 2021 Sep 15. pii: 2784419. doi: 10.1001/jama.2021.13462.

  303. ABBASI J
    SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    JAMA. 2021;326:901.

  304. ABBASI J
    Point-of-Care SARS-CoV-2 Variant Diagnostic in Development.
    JAMA. 2021;326:901.

  305. SLOMSKI A
    Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
    JAMA. 2021;326:800.

  306. BLUMENTHAL KG, Phadke NA, Bates DW
    Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.

  307. JONES JM, Stone M, Sulaeman H, Fink RV, et al
    Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
    PubMed     Abstract available

  308. UYOGA S, Adetifa IMO, Otiende M, Yegon C, et al
    Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.
    JAMA. 2021 Sep 2. pii: 2784014. doi: 10.1001/jama.2021.15265.

    August 2021
  309. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.

  310. WOOLFORD SJ, Sidell M, Li X, Else V, et al
    Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic.
    JAMA. 2021 Aug 27. pii: 2783690. doi: 10.1001/jama.2021.15036.

  311. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.

  312. KUEHN BM
    Drug-Resistant Pandemic Influenza Found at Texas Detention Facility.
    JAMA. 2021;326:692.

  313. KUEHN BM
    Post-COVID-19 Symptoms Were Worse Than Cancer's Effects.
    JAMA. 2021;326:692.

  314. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.

  315. VASAN A, Kenyon CC, Roberto CA, Fiks AG, et al
    Association of Remote vs In-Person Benefit Delivery With WIC Participation During the COVID-19 Pandemic.
    JAMA. 2021 Aug 20. pii: 2783501. doi: 10.1001/jama.2021.14356.

  316. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.

  317. CONGRAVE-WILSON Z, Lee Y, Jumarang J, Perez S, et al
    Change in Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection.
    JAMA. 2021 Aug 13. pii: 2783249. doi: 10.1001/jama.2021.13967.

  318. KADRI SS, Simpson SQ
    Potential Implications of SARS-CoV-2 Delta Variant Surges for Rural Areas and Hospitals.
    JAMA. 2021 Aug 12. pii: 2783233. doi: 10.1001/jama.2021.13941.

  319. SCHAEFER GO, Leland RJ, Emanuel EJ
    Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.
    JAMA. 2021 Aug 12. pii: 2783234. doi: 10.1001/jama.2021.13226.

  320. ABBASI J
    Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    JAMA. 2021;326:473.

  321. ABBASI J
    COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
    JAMA. 2021;326:473.

  322. ABBASI J
    Antigen Testing Every 3 Days Is Highly Sensitive for SARS-CoV-2.
    JAMA. 2021;326:473.

    A Pandemic of Lights.
    JAMA. 2021;326:481-482.

  324. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
    Myocarditis and Pericarditis After Vaccination for COVID-19.
    JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.

    July 2021
  325. BARBASH IJ, Kahn JM
    Fostering Hospital Resilience-Lessons From COVID-19.
    JAMA. 2021 Jul 29. pii: 2782738. doi: 10.1001/jama.2021.12484.

  326. ABBASI J
    Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
    JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.

  327. CARICCHIO R, Abbate A, Gordeev I, Meng J, et al
    Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
    JAMA. 2021;326:230-239.
    PubMed     Abstract available

  328. SIMON P, Ho A, Shah MD, Shetgiri R, et al
    Trends in Mortality From COVID-19 and Other Leading Causes of Death Among Latino vs White Individuals in Los Angeles County, 2011-2020.
    JAMA. 2021 Jul 19. pii: 2782334. doi: 10.1001/jama.2021.11945.

  329. OLDENBURG CE, Pinsky BA, Brogdon J, Chen C, et al
    Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.
    JAMA. 2021 Jul 16. pii: 2782166. doi: 10.1001/jama.2021.11517.
    PubMed     Abstract available

  330. HOLTGRAVE DR, Vermund SH, Wen LS
    Potential Benefits of Expanded COVID-19 Surveillance in the US.
    JAMA. 2021 Jul 15. pii: 2782163. doi: 10.1001/jama.2021.11211.

  331. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.

  332. ABBASI J
    Artificial Intelligence in COVID-19 Imaging Mismatched to the Clinic.
    JAMA. 2021;326:124.

  333. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
    Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
    PubMed     Abstract available

  334. KOFMAN A, Kantor R, Adashi EY
    Potential COVID-19 Endgame Scenarios: Eradication, Elimination, Cohabitation, or Conflagration?
    JAMA. 2021 Jul 8. pii: 2781945. doi: 10.1001/jama.2021.11042.

    A Stranger to Silence.
    JAMA. 2021;326:29-30.

  336. MATTHAY MA, Luetkemeyer AF
    IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?
    JAMA. 2021 Jul 6. pii: 2781881. doi: 10.1001/jama.2021.11121.

  337. SHANKAR-HARI M, Vale CL, Godolphin PJ, Fisher D, et al
    Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
    JAMA. 2021 Jul 6. pii: 2781880. doi: 10.1001/jama.2021.11330.
    PubMed     Abstract available

  338. WALKEY AJ, Law A, Bosch NA
    Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.
    JAMA. 2021 Jul 2. pii: 2781792. doi: 10.1001/jama.2021.11048.

  339. KAVANAGH MM, Gostin LO, Sunder M
    Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
    JAMA. 2021 Jul 1. pii: 2781756. doi: 10.1001/jama.2021.10823.

  340. PERSAD G, Emanuel EJ
    Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
    JAMA. 2021 Jul 1. pii: 2781755. doi: 10.1001/jama.2021.11045.

    June 2021
  341. RUBIN R
    Alcohol-Related Diseases Increased as Some People Drank More During the COVID-19 Pandemic.
    JAMA. 2021 Jun 30. pii: 2781739. doi: 10.1001/jama.2021.10626.

  342. SLOMSKI A
    Another COVID-19 Fallout: Teens' Happy Hour With Parents.
    JAMA. 2021 Jun 30. pii: 2781738. doi: 10.1001/jama.2021.11007.

  343. ORKIN AM, Gill PJ, Ghersi D, Campbell L, et al
    Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
    JAMA. 2021 Jun 21. pii: 2781397. doi: 10.1001/jama.2021.9941.
    PubMed     Abstract available

    New (Ab)normal: A Tale of 2 Pandemics.
    JAMA. 2021;325:2345.

  345. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.

  346. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
    Realizing the Potential of Maternal Influenza Vaccination.
    JAMA. 2021;325:2257-2259.

  347. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    PubMed     Abstract available

  348. ABBASI J
    "Nanotraps" Designed to Capture and Clear SARS-CoV-2.
    JAMA. 2021;325:2243.

  349. SIMON MA
    Responding to Intimate Partner Violence During Telehealth Clinical Encounters.
    JAMA. 2021;325:2307-2308.

    A Mother's Gold.
    JAMA. 2021;325:2253-2254.

  351. HAMMOUD MM, Standiford TC, Carmody JB
    The 2020-2021 Residency Application Cycle: Lessons Learned and Lingering Problems.
    JAMA. 2021;325:2249-2250.

  352. TALBOT TR
    COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
    JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.

  353. GOSTIN LO, Shaw J, Salmon DA
    Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
    JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.

  354. RYAN L
    Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
    JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.

  355. RUBIN R
    Could Statins Do More Than Lower Cholesterol in Patients With COVID-19?
    JAMA. 2021 Jun 3. pii: 2780872. doi: 10.1001/jama.2021.8201.

    Bamlanivimab for Prevention of COVID-19.
    JAMA. 2021 Jun 3. pii: 2780873. doi: 10.1001/jama.2021.7515.

  357. COHEN MS, Nirula A, Mulligan MJ, Novak RM, et al
    Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
    JAMA. 2021 Jun 3. pii: 2780870. doi: 10.1001/jama.2021.8828.
    PubMed     Abstract available

  358. SOLOMON MD, Nguyen-Huynh M, Leong TK, Alexander J, et al
    Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges.
    JAMA. 2021 Jun 2. pii: 2780794. doi: 10.1001/jama.2021.8414.

    May 2021
  359. AL KAABI N, Zhang Y, Xia S, Yang Y, et al
    Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
    JAMA. 2021 May 26. pii: 2780562. doi: 10.1001/jama.2021.8565.
    PubMed     Abstract available

  360. UYEKI TM, Wentworth DE, Jernigan DB
    Influenza Activity in the US During the 2020-2021 Season.
    JAMA. 2021 May 24. pii: 2780518. doi: 10.1001/jama.2021.6125.

  361. DALY M, Jones A, Robinson E
    Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021.
    JAMA. 2021 May 24. pii: 2780519. doi: 10.1001/jama.2021.8246.

  362. FAUST JS, Du C, Mayes KD, Li SX, et al
    Mortality From Drug Overdoses, Homicides, Unintentional Injuries, Motor Vehicle Crashes, and Suicides During the Pandemic, March-August 2020.
    JAMA. 2021 May 21. pii: 2780436. doi: 10.1001/jama.2021.8012.

  363. KUEHN BM
    Restrictive Policies Threaten Efforts to Stop 2 West Virginia HIV Outbreaks.
    JAMA. 2021 May 20. pii: 2780358. doi: 10.1001/jama.2021.7404.

  364. MURTHY S, Fontela P, Berry S
    Incorporating Adult Evidence Into Pediatric Research and Practice: Bayesian Designs to Expedite Obtaining Child-Specific Evidence.
    JAMA. 2021;325:1937-1938.

  365. COLLIER AY, McMahan K, Yu J, Tostanoski LH, et al
    Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
    JAMA. 2021 May 13. pii: 2780202. doi: 10.1001/jama.2021.7563.
    PubMed     Abstract available

  366. SNYDER RA
    A Good Mother.
    JAMA. 2021;325:1837-1838.

  367. AHMAD FB, Anderson RN
    The Leading Causes of Death in the US for 2020.
    JAMA. 2021;325:1829-1830.

  368. ABBASI J
    A Next-Generation Rapid, Accurate SARS-CoV-2 Antibody Test.
    JAMA. 2021;325:1825.

  369. DEMERLE K, Angus DC, Seymour CW
    Precision Medicine for COVID-19: Phenotype Anarchy or Promise Realized?
    JAMA. 2021 May 7. pii: 2779924. doi: 10.1001/jama.2021.5248.

  370. TANG L, Hijano DR, Gaur AH, Geiger TL, et al
    Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
    JAMA. 2021 May 6. pii: 2779854. doi: 10.1001/jama.2021.6564.

  371. ANGEL Y, Spitzer A, Henig O, Saiag E, et al
    Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    JAMA. 2021 May 6. pii: 2779853. doi: 10.1001/jama.2021.7152.
    PubMed     Abstract available

  372. ABBASI J
    Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants.
    JAMA. 2021 May 5. pii: 2779850. doi: 10.1001/jama.2021.7212.

  373. WALTER K
    An Inside Look at a Post-COVID-19 Clinic.
    JAMA. 2021 May 5. pii: 2779851. doi: 10.1001/jama.2021.2426.

  374. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
    JAMA. 2021 May 5. pii: 2779852. doi: 10.1001/jama.2021.7489.

  375. INOUYE SK
    The Importance of Delirium and Delirium Prevention in Older Adults During Lockdowns.
    JAMA. 2021;325:1779-1780.

    April 2021
  376. DUMITRIU D, Gyamfi-Bannerman C
    Understanding Risk for Newborns Born to SARS-CoV-2-Positive Mothers.
    JAMA. 2021 Apr 29. pii: 2779587. doi: 10.1001/jama.2021.6210.

  377. NORMAN M, Naver L, Soderling J, Ahlberg M, et al
    Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes.
    JAMA. 2021 Apr 29. pii: 2779586. doi: 10.1001/jama.2021.5775.
    PubMed     Abstract available

    COVID-19 and the "Lost Year" for Smokers Trying to Quit.
    JAMA. 2021 Apr 28. pii: 2779451. doi: 10.1001/jama.2021.5601.

  379. GILL PJ, Mahant S, Hall M, Berry JG, et al
    Reasons for Admissions to US Children's Hospitals During the COVID-19 Pandemic.
    JAMA. 2021;325:1676-1679.

  380. MASON M, Arukumar P, Feinglass J
    The Pandemic Stay-at-Home Order and Opioid-Involved Overdose Fatalities.
    JAMA. 2021 Apr 23. pii: 2779399. doi: 10.1001/jama.2021.6700.

  381. MCDERMOTT MM, Newman AB
    Remote Research and Clinical Trial Integrity During and After the Coronavirus Pandemic.
    JAMA. 2021 Apr 22. pii: 2779364. doi: 10.1001/jama.2021.4609.

  382. LARKIN H
    Navigating Attacks Against Health Care Workers in the COVID-19 Era.
    JAMA. 2021 Apr 21. pii: 2779310. doi: 10.1001/jama.2021.2701.

  383. ALLEN JG, Ibrahim AM
    Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission.
    JAMA. 2021 Apr 16. pii: 2779062. doi: 10.1001/jama.2021.5053.

  384. PERL SH, Uzan-Yulzari A, Klainer H, Asiskovich L, et al
    SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
    JAMA. 2021 Apr 12. pii: 2778766. doi: 10.1001/jama.2021.5782.

  385. BROWN KA, Gubbay J, Hopkins J, Patel S, et al
    S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021.
    JAMA. 2021 Apr 8. pii: 2778599. doi: 10.1001/jama.2021.5607.

  386. HAVERVALL S, Rosell A, Phillipson M, Mangsbo SM, et al
    Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers.
    JAMA. 2021 Apr 7. pii: 2778528. doi: 10.1001/jama.2021.5612.

  387. GOSTIN LO, Cohen IG, Shaw J
    Digital Health Passes in the Age of COVID-19: Are "Vaccine Passports" Lawful and Ethical?
    JAMA. 2021 Apr 7. pii: 2778526. doi: 10.1001/jama.2021.5283.

  388. FONTANAROSA PB, Bauchner H, Golub R
    To JAMA Authors, Reviewers, and Especially Physician Readers-A Profound Thank You.
    JAMA. 2021;325:1263-1265.

    Sitting in the River.
    JAMA. 2021;325:1255-1256.

  390. BEARD JH, Jacoby SF, Maher Z, Dong B, et al
    Changes in Shooting Incidence in Philadelphia, Pennsylvania, Between March and November 2020.
    JAMA. 2021;325:1327-1328.

  391. CHAPIN-BARDALES J, Gee J, Myers T
    Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
    JAMA. 2021 Apr 5. pii: 2778441. doi: 10.1001/jama.2021.5374.

  392. GUY GP JR, Massetti GM, Sauber-Schatz E
    Mask Mandates, On-Premises Dining, and COVID-19.
    JAMA. 2021 Apr 1. pii: 2778233. doi: 10.1001/jama.2021.5455.

    March 2021
  393. GRIECO DL, Menga LS, Cesarano M, Rosa T, et al
    Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.
    JAMA. 2021 Mar 25. pii: 2778088. doi: 10.1001/jama.2021.4682.
    PubMed     Abstract available

  394. MUNSHI L, Hall JB
    Respiratory Support During the COVID-19 Pandemic: Is It Time to Consider Using a Helmet?
    JAMA. 2021 Mar 25. pii: 2778089. doi: 10.1001/jama.2021.4975.

  395. ABBASI J
    How the US Failed to Prioritize SARS-CoV-2 Variant Surveillance.
    JAMA. 2021 Mar 24. pii: 2777988. doi: 10.1001/jama.2021.3368.

  396. SLOMSKI A
    Molecular Point-of-Care Test Improved Influenza Care.
    JAMA. 2021;325:1135.

  397. GOSTIN LO
    The Coronavirus Pandemic 1 Year On-What Went Wrong?
    JAMA. 2021;325:1132-1133.

  398. MEHTA A
    "Self-Portrait as Exit Wounds": A Graphic Story.
    JAMA. 2021;325:1127-1129.

  399. LEFRERE B, Recoing A, Delacour H
    COVID-19 Postage Stamps-Messages in a Message.
    JAMA. 2021 Mar 22. pii: 2777922. doi: 10.1001/jama.2021.2139.

  400. EDARA VV, Hudson WH, Xie X, Ahmed R, et al
    Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
    JAMA. 2021 Mar 19. pii: 2777898. doi: 10.1001/jama.2021.4388.

    Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19.
    JAMA. 2021 Mar 18. pii: 2777828. doi: 10.1001/jama.2021.4295.

  402. SADEGHIPOUR P, Talasaz AH, Rashidi F, Sharif-Kashani B, et al
    Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Cl
    JAMA. 2021 Mar 18. pii: 2777829. doi: 10.1001/jama.2021.4152.
    PubMed     Abstract available

  403. Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
    JAMA. 2021 Mar 17. pii: 2777786. doi: 10.1001/jama.2021.4121.

  404. RUBIN R
    COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.
    JAMA. 2021 Mar 17. pii: 2777785. doi: 10.1001/jama.2021.3370.

    Outcomes for Patients Following Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777784. doi: 10.1001/jama.2021.3430.

  406. MORIN L, Savale L, Pham T, Colle R, et al
    Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777787. doi: 10.1001/jama.2021.3331.
    PubMed     Abstract available

    2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
    JAMA. 2021;325:1029-1030.

  408. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
    JAMA. 2021 Mar 15. pii: 2777685. doi: 10.1001/jama.2021.4385.

  409. STEPHENSON KE, Le Gars M, Sadoff J, de Groot AM, et al
    Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
    JAMA. 2021 Mar 11. pii: 2777598. doi: 10.1001/jama.2021.3645.
    PubMed     Abstract available

  410. CHRISTIE A, Mbaeyi SA, Walensky RP
    CDC Interim Recommendations for Fully Vaccinated People: An Important First Step.
    JAMA. 2021 Mar 10. pii: 2777536. doi: 10.1001/jama.2021.4367.

  411. LI L, Neuroth LM, Valachovic E, Schwebel DC, et al
    Association Between Changes in Social Distancing Policies in Ohio and Traffic Volume and Injuries, January Through July 2020.
    JAMA. 2021;325:1003-1006.

  412. ABBASI J
    COVID-19 "Liquid Biopsy" Could Offer Monitoring, Prognostic Tool.
    JAMA. 2021;325:924.

  413. ABBASI J
    Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient.
    JAMA. 2021;325:924.

  414. ABBASI J
    Saliva Tests Comparable With Nasal Swabs for SARS-CoV-2 Detection.
    JAMA. 2021;325:924.

  415. BLUMENTHAL KG, Robinson LB, Camargo CA Jr, Shenoy ES, et al
    Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    JAMA. 2021 Mar 8. pii: 2777417. doi: 10.1001/jama.2021.3976.

  416. LOPEZ-MEDINA E, Lopez P, Hurtado IC, Davalos DM, et al
    Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.
    JAMA. 2021 Mar 4. pii: 2777389. doi: 10.1001/jama.2021.3071.
    PubMed     Abstract available

  417. MOORE JP
    Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.
    JAMA. 2021 Mar 4. pii: 2777390. doi: 10.1001/jama.2021.3465.

  418. DEL RIO C, Malani P
    COVID-19 in 2021-Continuing Uncertainty.
    JAMA. 2021 Mar 4. pii: 2777391. doi: 10.1001/jama.2021.3760.

  419. MURRAY CJL, Piot P
    The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
    JAMA. 2021 Mar 3. pii: 2777343. doi: 10.1001/jama.2021.2828.

  420. STEAD W
    It's Not Your Fault.
    JAMA. 2021;325:827-828.

  421. SHEPHERD JP, Moore SC, Long A, Mercer Kollar LM, et al
    Association Between COVID-19 Lockdown Measures and Emergency Department Visits for Violence-Related Injuries in Cardiff, Wales.
    JAMA. 2021;325:885-887.

  422. SAADAT S, Tehrani ZR, Logue J, Newman M, et al
    Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
    JAMA. 2021 Mar 1. pii: 2777171. doi: 10.1001/jama.2021.3341.

  423. LIVINGSTON EH, Malani PN, Creech CB
    The Johnson & Johnson Vaccine for COVID-19.
    JAMA. 2021 Mar 1. pii: 2777172. doi: 10.1001/jama.2021.2927.

    February 2021
  424. ANGUS DC, Gordon AC, Bauchner H
    Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.
    JAMA. 2021 Feb 26. pii: 2777058. doi: 10.1001/jama.2021.3284.

  425. JANIAUD P, Axfors C, Schmitt AM, Gloy V, et al
    Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    JAMA. 2021 Feb 26. pii: 2777060. doi: 10.1001/jama.2021.2747.
    PubMed     Abstract available

  426. CREECH CB, Walker SC, Samuels RJ
    SARS-CoV-2 Vaccines.
    JAMA. 2021 Feb 26. pii: 2777059. doi: 10.1001/jama.2021.3199.

  427. FELDSTEIN LR, Tenforde MW, Friedman KG, Newhams M, et al
    Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
    JAMA. 2021 Feb 24. pii: 2777026. doi: 10.1001/jama.2021.2091.
    PubMed     Abstract available

  428. RUBIN R
    Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
    JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.

  429. GHARPURE R, Patel A, Link-Gelles R
    First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
    JAMA. 2021 Feb 24. pii: 2777023. doi: 10.1001/jama.2021.2352.

  430. MEEKS LM
    COVID-19 Communication-The Need for Humanity, Empathy, and Grace.
    JAMA. 2021;325:725-726.

    From Economic Recovery to Health Resilience.
    JAMA. 2021;325:710-711.

  432. PIZZO PA, Spiegel D, Mello MM
    When Physicians Engage in Practices That Threaten the Nation's Health.
    JAMA. 2021;325:723-724.

  433. TENFORDE MW, Fisher KA, Patel MM
    Identifying COVID-19 Risk Through Observational Studies to Inform Control Measures.
    JAMA. 2021 Feb 22. pii: 2776937. doi: 10.1001/jama.2021.1995.

  434. NELSON EJ, McKune SL, Ryan KA, Lednicky JA, et al
    SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases.
    JAMA. 2021 Feb 19. pii: 2776857. doi: 10.1001/jama.2021.2392.

  435. RUBIN R
    The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
    JAMA. 2021 Feb 18. pii: 2776787. doi: 10.1001/jama.2021.0641.

  436. LEAF DE, Ginde AA
    Vitamin D3 to Treat COVID-19: Different Disease, Same Answer.
    JAMA. 2021 Feb 17. pii: 2776736. doi: 10.1001/jama.2020.26850.

  437. WALENSKY RP, Walke HT, Fauci AS
    SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
    JAMA. 2021 Feb 17. pii: 2776739. doi: 10.1001/jama.2021.2294.

  438. MURAI IH, Fernandes AL, Sales LP, Pinto AJ, et al
    Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
    JAMA. 2021 Feb 17. pii: 2776738. doi: 10.1001/jama.2020.26848.
    PubMed     Abstract available

  439. RASCHKE RA, Agarwal S, Rangan P, Heise CW, et al
    Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation.
    JAMA. 2021 Feb 17. pii: 2776737. doi: 10.1001/jama.2021.1545.

  440. SHARFSTEIN JM, Goodman JL, Borio L
    The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    JAMA. 2021 Feb 15. pii: 2776658. doi: 10.1001/jama.2021.1961.

  441. MASCOLA JR, Graham BS, Fauci AS
    SARS-CoV-2 Viral Variants-Tackling a Moving Target.
    JAMA. 2021 Feb 11. pii: 2776542. doi: 10.1001/jama.2021.2088.

  442. ZHANG W, Davis BD, Chen SS, Sincuir Martinez JM, et al
    Emergence of a Novel SARS-CoV-2 Variant in Southern California.
    JAMA. 2021 Feb 11. pii: 2776543. doi: 10.1001/jama.2021.1612.

  443. Experts Discuss COVID-19-Vaccine Doses, Virus Variants, and More.
    JAMA. 2021 Feb 10. pii: 2776539. doi: 10.1001/jama.2021.1101.

  444. ABBASI J
    Researchers Investigate What COVID-19 Does to the Heart.
    JAMA. 2021 Feb 10. pii: 2776538. doi: 10.1001/jama.2021.0107.

  445. BROOKS JT, Butler JC
    Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2.
    JAMA. 2021 Feb 10. pii: 2776536. doi: 10.1001/jama.2021.1505.

  446. BIANCHI DW, Kaeser L, Cernich AN
    Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
    JAMA. 2021 Feb 10. pii: 2776540. doi: 10.1001/jama.2021.1865.

  447. NARAYAN KMV, Curran JW, Foege WH
    The COVID-19 Pandemic as an Opportunity to Ensure a More Successful Future for Science and Public Health.
    JAMA. 2021;325:525-526.

  448. MOURAD MS
    Donning and Doffing.
    JAMA. 2021;325:536.

  449. TAN IB, Tan C, Hsu LY, Dan YY, et al
    Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore.
    JAMA. 2021;325:584-585.

  450. ESCALANTE E, Golden RL, Mason DJ
    Social Isolation and Loneliness: Imperatives for Health Care in a Post-COVID World.
    JAMA. 2021;325:520-521.

  451. ABBASI J
    CRISPR-Based COVID-19 Smartphone Test in Development.
    JAMA. 2021;325:522.

  452. ABBASI J
    Predicting COVID-19 Outcomes in Emergency Department Patients.
    JAMA. 2021;325:522.

  453. RUBIN R
    Helping People Who Are Homeless Stay Healthy During the Pandemic.
    JAMA. 2021;325:517-519.

  454. ADHIKARI EH, Spong CY
    COVID-19 Vaccination in Pregnant and Lactating Women.
    JAMA. 2021 Feb 8. pii: 2776449. doi: 10.1001/jama.2021.1658.

  455. RASMUSSEN SA, Jamieson DJ
    Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
    JAMA. 2021 Feb 8. pii: 2776447. doi: 10.1001/jama.2021.1683.

    A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
    JAMA. 2021 Feb 5. pii: 2776308. doi: 10.1001/jama.2020.26792.

  457. LLOYD EC, Gandhi TN, Petty LA
    Monoclonal Antibodies for COVID-19.
    JAMA. 2021 Feb 5. pii: 2776307. doi: 10.1001/jama.2021.1225.

  458. MOHANAN M, Malani A, Krishnan K, Acharya A, et al
    Prevalence of SARS-CoV-2 in Karnataka, India.
    JAMA. 2021 Feb 4. pii: 2776292. doi: 10.1001/jama.2021.0332.

    Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
    JAMA. 2021 Feb 3. pii: 2776229. doi: 10.1001/jama.2021.1375.

  460. REN R, Zhang Y, Li Q, McGoogan JM, et al
    Asymptomatic SARS-CoV-2 Infections Among Persons Entering China From April 16 to October 12, 2020.
    JAMA. 2021;325:489-492.

  461. ZULMAN DM, Verghese A
    Virtual Care, Telemedicine Visits, and Real Connection in the Era of COVID-19: Unforeseen Opportunity in the Face of Adversity.
    JAMA. 2021;325:437-438.

  462. HAMPTON T
    Autoantibodies May Drive COVID-19 Blood Clots.
    JAMA. 2021;325:425.

  463. MEHROTRA A, Bhatia RS, Snoswell CL
    Paying for Telemedicine After the Pandemic.
    JAMA. 2021;325:431-432.

  464. USCHER-PINES L, Sousa J, Jones M, Whaley C, et al
    Telehealth Use Among Safety-Net Organizations in California During the COVID-19 Pandemic.
    JAMA. 2021 Feb 2. pii: 2776166. doi: 10.1001/jama.2021.0282.

  465. OULDALI N, Toubiana J, Antona D, Javouhey E, et al
    Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
    JAMA. 2021 Feb 1. pii: 2776054. doi: 10.1001/jama.2021.0694.
    PubMed     Abstract available

    January 2021
  466. JEAN-JACQUES M, Bauchner H
    Vaccine Distribution-Equity Left Behind?
    JAMA. 2021 Jan 29. pii: 2776053. doi: 10.1001/jama.2021.1205.

  467. MOORE JP, Offit PA
    SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
    JAMA. 2021 Jan 28. pii: 2776039. doi: 10.1001/jama.2021.1114.

  468. LEVY JF, Ippolito BN, Jain A
    Hospital Revenue Under Maryland's Total Cost of Care Model During the COVID-19 Pandemic, March-July 2020.
    JAMA. 2021;325:398-400.

  469. RUBIN R
    Funding Efforts to Reduce COVID-19 Testing Hesitancy.
    JAMA. 2021;325:333.

  470. VEIRA O, Sharfstein JM
    "This Level of Death, It's New"-Health Care Workers in Their Own Words.
    JAMA. 2021;325:331-332.

  471. KUEHN BM
    Africa Succeeded Against COVID-19's First Wave, but the Second Wave Brings New Challenges.
    JAMA. 2021;325:327-328.

  472. HONEIN MA, Barrios LC, Brooks JT
    Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection.
    JAMA. 2021 Jan 26. pii: 2775875. doi: 10.1001/jama.2021.0374.

  473. LOPEZ L 3RD, Hart LH 3rd, Katz MH
    Racial and Ethnic Health Disparities Related to COVID-19.
    JAMA. 2021 Jan 22. pii: 2775687. doi: 10.1001/jama.2020.26443.

  474. CRANE MA, Shermock KM, Omer SB, Romley JA, et al
    Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020.
    JAMA. 2021 Jan 22. pii: 2775686. doi: 10.1001/jama.2021.0286.

  475. MALANI PN, Golub RM
    Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19.
    JAMA. 2021 Jan 21. pii: 2775645. doi: 10.1001/jama.2021.0585.

  476. GOTTLIEB RL, Nirula A, Chen P, Boscia J, et al
    Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2021 Jan 21. pii: 2775647. doi: 10.1001/jama.2021.0202.
    PubMed     Abstract available

  477. LOPES RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, et al
    Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
    JAMA. 2021;325:254-264.
    PubMed     Abstract available

  478. WOO K, Rigberg D, Lawrence PF
    Safe Central Venous Access in an Overburdened Health System.
    JAMA. 2021;325:299-300.

    Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic.
    JAMA. 2021 Jan 14. pii: 2775400. doi: 10.1001/jama.2020.25384.

  480. ABBASI J
    Broad, Durable Antibody Response in Universal Flu Vaccine Trial.
    JAMA. 2021;325:121.

  481. RUBIN R
    Sorting Out Whether Vitamin D Deficiency Raises COVID-19 Risk.
    JAMA. 2021 Jan 6. pii: 2775003. doi: 10.1001/jama.2020.24127.

  482. LAURING AS, Hodcroft EB
    Genetic Variants of SARS-CoV-2-What Do They Mean?
    JAMA. 2021 Jan 6. pii: 2775006. doi: 10.1001/jama.2020.27124.

  483. LARGENT EA, Miller FG
    Problems With Paying People to Be Vaccinated Against COVID-19.
    JAMA. 2021 Jan 6. pii: 2775005. doi: 10.1001/jama.2020.27121.

  484. GOSTIN LO
    A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    JAMA. 2021;325:17-18.

    A Medical and Scientific New Year's Wish List.
    JAMA. 2021;325:29-30.

  486. WHITE K, Kumar B, Goyal V, Wallace R, et al
    Changes in Abortion in Texas Following an Executive Order Ban During the Coronavirus Pandemic.
    JAMA. 2021 Jan 4. pii: 2774731. doi: 10.1001/jama.2020.24096.

    December 2020
  487. ABBASI J
    COVID-19 Conspiracies and Beyond: How Physicians Can Deal With Patients' Misinformation.
    JAMA. 2020 Dec 30. pii: 2774709. doi: 10.1001/jama.2020.22018.

  488. GOSTIN LO, Salmon DA, Larson HJ
    Mandating COVID-19 Vaccines.
    JAMA. 2020 Dec 29. pii: 2774712. doi: 10.1001/jama.2020.26553.

  489. CORRIGAN JM, Clancy CM
    Assessing Progress in Health Care Quality Through the Lens of COVID-19.
    JAMA. 2020;324:2483-2484.

  490. KADRI SS, Gundrum J, Warner S, Cao Z, et al
    Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations.
    JAMA. 2020;324:2553-2554.

  491. RUBIN R
    Pharmacies Partner With HHS to Provide COVID-19 Vaccines.
    JAMA. 2020;324:2475.

  492. RUBIN R
    More Transparency Needed for COVID-19 Emergency Authorizations.
    JAMA. 2020;324:2475.

  493. DZAU VJ, Shine KI
    Two Decades Since To Err Is Human: Progress, but Still a "Chasm".
    JAMA. 2020;324:2489-2490.

  494. GREEN MJ, Wall S
    Graphic Medicine-The Best of 2020.
    JAMA. 2020;324:2469-2471.

  495. HU NY
    Who Is the Parasite?-COVID-19 and Structural Narratives of Health Inequity.
    JAMA. 2020 Dec 21. pii: 2774539. doi: 10.1001/jama.2020.21450.

  496. KOH HK, Geller AC, VanderWeele TJ
    Deaths From COVID-19.
    JAMA. 2020 Dec 17. pii: 2774464. doi: 10.1001/jama.2020.25381.

  497. WOOLF SH, Chapman DA, Lee JH
    COVID-19 as the Leading Cause of Death in the United States.
    JAMA. 2020 Dec 17. pii: 2774465. doi: 10.1001/jama.2020.24865.

    Surgeon Fills COVID-19 Testing Gap in Philadelphia's Black Neighborhoods.
    JAMA. 2020 Dec 16. pii: 2774446. doi: 10.1001/jama.2020.22796.

  499. FAUST JS, Krumholz HM, Du C, Mayes KD, et al
    All-Cause Excess Mortality and COVID-19-Related Mortality Among US Adults Aged 25-44 Years, March-July 2020.
    JAMA. 2020 Dec 16. pii: 2774445. doi: 10.1001/jama.2020.24243.

  500. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
    JAMA. 2020;324:2354-2355.

  501. CANCE JD, Doyle E
    Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic.
    JAMA. 2020;324:2442-2444.

  502. HUSKAMP HA, Busch AB, Uscher-Pines L, Barnett ML, et al
    Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic.
    JAMA. 2020;324:2440-2442.

  503. BAKER DW
    Trust in Health Care in the Time of COVID-19.
    JAMA. 2020;324:2373-2375.

  504. ABBASI J
    JAMA Network Articles of the Year 2020.
    JAMA. 2020;324:2350-2353.

  505. VOLPP KG, Loewenstein G, Buttenheim AM
    Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program.
    JAMA. 2020 Dec 14. pii: 2774381. doi: 10.1001/jama.2020.24036.

  506. RID A, Lipsitch M, Miller FG
    The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    JAMA. 2020 Dec 14. pii: 2774382. doi: 10.1001/jama.2020.25053.

  507. JOFFE S
    Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    JAMA. 2020 Dec 14. pii: 2774383. doi: 10.1001/jama.2020.25127.

  508. DONNELLY JP, Wang XQ, Iwashyna TJ, Prescott HC, et al
    Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System.
    JAMA. 2020 Dec 14. pii: 2774380. doi: 10.1001/jama.2020.21465.

  509. CAMPO R, New E
    The Art of Losing-Three Poems for the COVID-19 Pandemic.
    JAMA. 2020 Dec 11. pii: 2774325. doi: 10.1001/jama.2020.24699.

  510. An EUA for Bamlanivimab-A Monoclonal Antibody for COVID-19.
    JAMA. 2020 Dec 11. pii: 2774326. doi: 10.1001/jama.2020.24415.

  511. BUTLER SM
    Four COVID-19 Lessons for Achieving Health Equity.
    JAMA. 2020;324:2245-2246.

  512. ABBASI J
    Using Smartwatch Data to Detect COVID-19 Cases Early.
    JAMA. 2020;324:2247.

  513. MILLER BL
    Science Denial and COVID Conspiracy Theories: Potential Neurological Mechanisms and Possible Responses.
    JAMA. 2020;324:2255-2256.

  514. HANDLEY SC, Mullin AM, Elovitz MA, Gerson KD, et al
    Changes in Preterm Birth Phenotypes and Stillbirth at 2 Philadelphia Hospitals During the SARS-CoV-2 Pandemic, March-June 2020.
    JAMA. 2020 Dec 7. pii: 2774087. doi: 10.1001/jama.2020.20991.

  515. STOWE J, Smith H, Thurland K, Ramsay ME, et al
    Stillbirths During the COVID-19 Pandemic in England, April-June 2020.
    JAMA. 2020 Dec 7. pii: 2774088. doi: 10.1001/jama.2020.21369.

  516. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.

  517. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    PubMed     Abstract available

  518. GOLDSTEIN RH, Walensky RP
    The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access.
    JAMA. 2020;324:2151-2152.

  519. GOSTIN LO, Parmet WE, Rosenbaum S
    Health Policy in the Supreme Court and a New Conservative Majority.
    JAMA. 2020;324:2157-2158.

    November 2020
  520. DESAI AN, Majumder MS
    What Is Herd Immunity?
    JAMA. 2020;324:2113.

  521. PIAZZA G, Morrow DA
    Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19.
    JAMA. 2020 Nov 23. pii: 2773516. doi: 10.1001/jama.2020.23422.

  522. MCGINTY EE, Presskreischer R, Anderson KE, Han H, et al
    Psychological Distress and COVID-19-Related Stressors Reported in a Longitudinal Cohort of US Adults in April and July 2020.
    JAMA. 2020 Nov 23. pii: 2773517. doi: 10.1001/jama.2020.21231.

  523. VAHIA IV, Jeste DV, Reynolds CF 3rd
    Older Adults and the Mental Health Effects of COVID-19.
    JAMA. 2020 Nov 20. pii: 2773479. doi: 10.1001/jama.2020.21753.

  524. LURIE N, Experton B
    How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
    JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.

  525. DATTA SD, Talwar A, Lee JT
    A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications.
    JAMA. 2020 Nov 18. pii: 2773338. doi: 10.1001/jama.2020.22717.

  526. TAYLOR SP
    Shear Forces.
    JAMA. 2020;324:1943-1944.

  527. WANG EA, Western B, Berwick DM
    COVID-19, Decarceration, and the Role of Clinicians, Health Systems, and Payers: A Report From the National Academy of Sciences, Engineering, and Medicine.
    JAMA. 2020 Nov 16. pii: 2773226. doi: 10.1001/jama.2020.22109.

  528. MANABE YC, Sharfstein JS, Armstrong K
    The Need for More and Better Testing for COVID-19.
    JAMA. 2020 Nov 13. pii: 2773129. doi: 10.1001/jama.2020.21694.

  529. RICHTERMAN A, Meyerowitz EA, Cevik M
    Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health.
    JAMA. 2020 Nov 13. pii: 2773128. doi: 10.1001/jama.2020.21399.

  530. SEYMOUR CW, Bauchner H, Golub RM
    COVID-19 Infection-Preventing Clinical Deterioration.
    JAMA. 2020 Nov 12. pii: 2773107. doi: 10.1001/jama.2020.21720.

  531. LENZE EJ, Mattar C, Zorumski CF, Stevens A, et al
    Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Nov 12. pii: 2773108. doi: 10.1001/jama.2020.22760.
    PubMed     Abstract available

  532. ABBASI J
    Younger Adults Caught in COVID-19 Crosshairs as Demographics Shift.
    JAMA. 2020 Nov 11. pii: 2773055. doi: 10.1001/jama.2020.21913.

  533. KIM PS, Read SW, Fauci AS
    Therapy for Early COVID-19: A Critical Need.
    JAMA. 2020 Nov 11. pii: 2773058. doi: 10.1001/jama.2020.22813.

    Reflections of a COVID-19 Long Hauler.
    JAMA. 2020 Nov 11. pii: 2773056. doi: 10.1001/jama.2020.22130.

  535. GOSTIN LO
    The Great Coronavirus Pandemic of 2020-7 Critical Lessons.
    JAMA. 2020;324:1816-1817.

  536. ABBASI J
    COVID-19 Antibody Tests Perform Well in Head-to-Head Comparison.
    JAMA. 2020;324:1818.

  537. SELF WH, Semler MW, Leither LM, Casey JD, et al
    Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Nov 9. pii: 2772922. doi: 10.1001/jama.2020.22240.
    PubMed     Abstract available

  538. SAAG MS
    Misguided Use of Hydroxychloroquine for COVID-19: The Infusion of Politics Into Science.
    JAMA. 2020 Nov 9. pii: 2772921. doi: 10.1001/jama.2020.22389.

  539. RUBIN R
    First It Was Masks; Now Some Refuse Testing for SARS-CoV-2.
    JAMA. 2020 Nov 6. pii: 2772860. doi: 10.1001/jama.2020.22003.

  540. PANDIT JA
    Memento Mori.
    JAMA. 2020;324:1731-1732.

  541. PLOTT CF, Kachalia AB, Sharfstein JM
    Unexpected Health Insurance Profits and the COVID-19 Crisis.
    JAMA. 2020;324:1713-1714.

  542. HAMPTON T
    Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses.
    JAMA. 2020;324:1712.

  543. UYEKI TM
    High-risk Groups for Influenza Complications.
    JAMA. 2020 Nov 2. pii: 2772692. doi: 10.1001/jama.2020.21869.

  544. UYEKI TM, Santoli J, Jernigan DB
    Preparing for the 2020-2021 Influenza Season.
    JAMA. 2020 Nov 2. pii: 2772691. doi: 10.1001/jama.2020.21849.

    October 2020
  545. LO NC, Nyathi S, Chapman LAC, Rodriguez-Barraquer I, et al
    Influenza, Varicella, and Mumps Outbreaks in US Migrant Detention Centers.
    JAMA. 2020 Oct 29. pii: 2772626. doi: 10.1001/jama.2020.20539.

  546. ERFANI P, Uppal N, Lee CH, Mishori R, et al
    COVID-19 Testing and Cases in Immigration Detention Centers, April-August 2020.
    JAMA. 2020 Oct 29. pii: 2772627. doi: 10.1001/jama.2020.21473.

    Nursing Homes' Next Test-Vaccinating Workers Against COVID-19.
    JAMA. 2020 Oct 28. pii: 2772581. doi: 10.1001/jama.2020.21354.

  548. GONDI S, Chokshi DA
    Financial Stability as a Goal of Payment Reform-A Lesson From COVID-19.
    JAMA. 2020;324:1596-1597.

  549. RUBIN R
    Substance Use Disorder Linked to Higher COVID-19 Risk.
    JAMA. 2020;324:1598.

  550. LERNER AM, Folkers GK, Fauci AS
    Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions.
    JAMA. 2020 Oct 26. pii: 2772459. doi: 10.1001/jama.2020.21946.

  551. BELL BP, Romero JR, Lee GM
    Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
    JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.

  552. RUBIN R
    The Challenges of Expanding Rapid Tests to Curb COVID-19.
    JAMA. 2020 Oct 21. pii: 2772299. doi: 10.1001/jama.2020.21106.

  553. BAUCHNER H, Fontanarosa PB
    Excess Deaths and the Great Pandemic of 2020.
    JAMA. 2020;324:1504-1505.

  554. OMER SB, Yildirim I, Forman HP
    Herd Immunity and Implications for SARS-CoV-2 Control.
    JAMA. 2020 Oct 19. pii: 2772167. doi: 10.1001/jama.2020.20892.

  555. LEE GM, Romero JR, Bell BP
    Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.

  556. GOODMAN JL, Grabenstein JD, Braun MM
    Answering Key Questions About COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.

  557. PATEL MM, Jackson ML, Ferdinands J
    Postlicensure Evaluation of COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.

  558. SEYMOUR CW, McCreary EK, Stegenga J
    Sensible Medicine-Balancing Intervention and Inaction During the COVID-19 Pandemic.
    JAMA. 2020 Oct 15. pii: 2772072. doi: 10.1001/jama.2020.20271.

  559. ABBASI J
    Large Meta-analysis Digs Into Obesity's COVID-19 Risks.
    JAMA. 2020 Oct 15. pii: 2772071. doi: 10.1001/jama.2020.18637.

  560. SAAG MS, Gandhi RT, Hoy JF, Landovitz RJ, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2020 Oct 14. pii: 2771873. doi: 10.1001/jama.2020.17025.
    PubMed     Abstract available

  561. SCHMIDT H, Gostin LO, Williams MA
    Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.

  562. LEVITT L
    Trump vs Biden on Health Care.
    JAMA. 2020;324:1384-1385.

  563. ABBASI J
    Portable MRI-Coming to the ICU?
    JAMA. 2020;324:1386.

  564. ABBASI J
    Combining Rapid PCR and Antibody Tests Improved COVID-19 Diagnosis.
    JAMA. 2020;324:1386.

  565. COOPER LA, Williams DR
    Excess Deaths From COVID-19, Community Bereavement, and Restorative Justice for Communities of Color.
    JAMA. 2020 Oct 12. pii: 2771762. doi: 10.1001/jama.2020.19567.

  566. SIMON NM, Saxe GN, Marmar CR
    Mental Health Disorders Related to COVID-19-Related Deaths.
    JAMA. 2020 Oct 12. pii: 2771763. doi: 10.1001/jama.2020.19632.

    The Toll of COVID-19.
    JAMA. 2020 Oct 12. pii: 2771759. doi: 10.1001/jama.2020.20019.

  568. CUTLER DM, Summers LH
    The COVID-19 Pandemic and the $16 Trillion Virus.
    JAMA. 2020 Oct 12. pii: 2771764. doi: 10.1001/jama.2020.19759.

  569. WOOLF SH, Chapman DA, Sabo RT, Weinberger DM, et al
    Excess Deaths From COVID-19 and Other Causes, March-July 2020.
    JAMA. 2020 Oct 12. pii: 2771761. doi: 10.1001/jama.2020.19545.

  570. BILINSKI A, Emanuel EJ
    COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries.
    JAMA. 2020 Oct 12. pii: 2771841. doi: 10.1001/jama.2020.20717.

  571. HAMPTON T
    Insight on Sex-Based Immunity Differences, With COVID-19 Implications.
    JAMA. 2020;324:1274.

    Calming the Storm.
    JAMA. 2020;324:1290-1291.

  573. MEREDITH JW, High KP, Freischlag JA
    Preserving Elective Surgeries in the COVID-19 Pandemic and the Future.
    JAMA. 2020 Oct 5. pii: 2771580. doi: 10.1001/jama.2020.19594.

  574. DEL RIO C, Collins LF, Malani P
    Long-term Health Consequences of COVID-19.
    JAMA. 2020 Oct 5. pii: 2771581. doi: 10.1001/jama.2020.19719.

  575. Influenza Vaccine for 2020-2021.
    JAMA. 2020 Oct 2. pii: 2771510. doi: 10.1001/jama.2020.19507.

  576. POMBAL R, Hosegood I, Powell D
    Risk of COVID-19 During Air Travel.
    JAMA. 2020 Oct 1. pii: 2771435. doi: 10.1001/jama.2020.19108.

    September 2020
  577. FREANEY PM, Shah SJ, Khan SS
    COVID-19 and Heart Failure With Preserved Ejection Fraction.
    JAMA. 2020 Sep 30. pii: 2771385. doi: 10.1001/jama.2020.17445.

  578. WALKE HT, Honein MA, Redfield RR
    Preventing and Responding to COVID-19 on College Campuses.
    JAMA. 2020 Sep 29. pii: 2771319. doi: 10.1001/jama.2020.20027.

    The 2020 Lasker Awards and the COVID-19 Pandemic.
    JAMA. 2020 Sep 25. pii: 2770711. doi: 10.1001/jama.2020.17056.

  580. EL MOHEB M, Naar L, Christensen MA, Kapoen C, et al
    Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19.
    JAMA. 2020 Sep 24. pii: 2771160. doi: 10.1001/jama.2020.19400.

  581. AHLBERG M, Neovius M, Saltvedt S, Soderling J, et al
    Association of SARS-CoV-2 Test Status and Pregnancy Outcomes.
    JAMA. 2020 Sep 23. pii: 2771110. doi: 10.1001/jama.2020.19124.

  582. RUBIN R
    As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts.
    JAMA. 2020 Sep 23. pii: 2771111. doi: 10.1001/jama.2020.17709.

    JAMA Health Forum and COVID-19.
    JAMA. 2020;324:1155-1156.

    Ophthalmology and COVID-19.
    JAMA. 2020;324:1143-1144.

  585. DISIS ML
    Oncology and COVID-19.
    JAMA. 2020;324:1141-1142.

  586. WINKELMAYER WC, Khairallah P, Charytan DM
    Nephrology and COVID-19.
    JAMA. 2020;324:1137-1138.

    Otolaryngology-Head and Neck Surgery and COVID-19.
    JAMA. 2020;324:1145-1146.

  588. SHINKAI K, Bruckner AL
    Dermatology and COVID-19.
    JAMA. 2020;324:1133-1134.

  589. RIVARA FP, Fihn SD, Perencevich EN
    JAMA Network Open and COVID-19.
    JAMA. 2020;324:1153-1154.

  590. KIBBE MR
    Surgery and COVID-19.
    JAMA. 2020;324:1151-1152.

  591. REDBERG RF, Katz M, Steinbrook R
    Internal Medicine and COVID-19.
    JAMA. 2020;324:1135-1136.

  592. BONOW RO, O'Gara PT, Yancy CW
    Cardiology and COVID-19.
    JAMA. 2020;324:1131-1132.

    Pediatrics and COVID-19.
    JAMA. 2020;324:1147-1148.

  594. ONGUR D, Perlis R, Goff D
    Psychiatry and COVID-19.
    JAMA. 2020;324:1149-1150.

  595. JOSEPHSON SA, Kamel H
    Neurology and COVID-19.
    JAMA. 2020;324:1139-1140.

  596. BERKWITS M, Flanagin A, Bauchner H, Fontanarosa PB, et al
    The COVID-19 Pandemic and the JAMA Network.
    JAMA. 2020;324:1159-1160.

    Running on Fumes.
    JAMA. 2020;324:1157-1158.

  598. TISCH CF
    Camping Alone-Recovering From COVID-19.
    JAMA. 2020 Sep 21. pii: 2771024. doi: 10.1001/jama.2020.19304.

  599. ABBOTT J, Johnson D, Wynia M
    Ensuring Adequate Palliative and Hospice Care During COVID-19 Surges.
    JAMA. 2020 Sep 21. pii: 2771025. doi: 10.1001/jama.2020.16843.

  600. HALEY DF, Saitz R
    The Opioid Epidemic During the COVID-19 Pandemic.
    JAMA. 2020 Sep 18. pii: 2770985. doi: 10.1001/jama.2020.18543.

  601. WAINWRIGHT JJ, Mikre M, Whitley P, Dawson E, et al
    Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak.
    JAMA. 2020 Sep 18. pii: 2770987. doi: 10.1001/jama.2020.17694.

  602. OCHALEK TA, Cumpston KL, Wills BK, Gal TS, et al
    Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic.
    JAMA. 2020 Sep 18. pii: 2770986. doi: 10.1001/jama.2020.17477.

  603. PATEL MM, Thornburg NJ, Stubblefield WB, Talbot HK, et al
    Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.
    JAMA. 2020 Sep 17. pii: 2770928. doi: 10.1001/jama.2020.18796.

  604. ABBASI J
    The Science of Persuasion Offers Lessons for COVID-19 Prevention.
    JAMA. 2020 Sep 16. pii: 2770888. doi: 10.1001/jama.2020.15139.

  605. RUBIN R
    Investigating Whether Blood Type Is Linked to COVID-19 Risk.
    JAMA. 2020 Sep 16. pii: 2770889. doi: 10.1001/jama.2020.16516.

  606. NUZZO JB, Bell JA, Cameron EE
    Suboptimal US Response to COVID-19 Despite Robust Capabilities and Resources.
    JAMA. 2020 Sep 16. pii: 2770891. doi: 10.1001/jama.2020.17395.

  607. MICHAELS D, Wagner GR
    Occupational Safety and Health Administration (OSHA) and Worker Safety During the COVID-19 Pandemic.
    JAMA. 2020 Sep 16. pii: 2770890. doi: 10.1001/jama.2020.16343.

  608. SLOMSKI A
    Telehealth Success Spurs a Call for Greater Post-COVID-19 License Portability.
    JAMA. 2020;324:1021-1022.

  609. WOLINETZ CD, Collins FS
    Recognition of Research Participants' Need for Autonomy: Remembering the Legacy of Henrietta Lacks.
    JAMA. 2020;324:1027-1028.

  610. CUTLER D
    New Rules for the Pandemic Era.
    JAMA. 2020;324:1023-1024.

  611. STEPHENS DS, McElrath MJ
    COVID-19 and the Path to Immunity.
    JAMA. 2020 Sep 11. pii: 2770758. doi: 10.1001/jama.2020.16656.

  612. BAUCHNER H, Malani PN, Sharfstein J
    Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine.
    JAMA. 2020 Sep 10. pii: 2770681. doi: 10.1001/jama.2020.18860.

  613. PERSAD G, Peek ME, Emanuel EJ
    Fairly Prioritizing Groups for Access to COVID-19 Vaccines.
    JAMA. 2020 Sep 10. pii: 2770684. doi: 10.1001/jama.2020.18513.

  614. RODGERS GP, Gibbons GH
    Obesity and Hypertension in the Time of COVID-19.
    JAMA. 2020 Sep 9. pii: 2770253. doi: 10.1001/jama.2020.16753.

  615. MCCOY MS, Libert T, Buckler D, Grande DT, et al
    Prevalence of Third-Party Tracking on COVID-19-Related Web Pages.
    JAMA. 2020 Sep 8. pii: 2770565. doi: 10.1001/jama.2020.16178.

  616. ABBASI J
    COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
    JAMA. 2020 Sep 3. pii: 2770485. doi: 10.1001/jama.2020.16866.

  617. ANGUS DC, Derde L, Al-Beidh F, Annane D, et al
    Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
    JAMA. 2020 Sep 2. pii: 2770278. doi: 10.1001/jama.2020.17022.
    PubMed     Abstract available

  618. TOMAZINI BM, Maia IS, Cavalcanti AB, Berwanger O, et al
    Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
    JAMA. 2020 Sep 2. pii: 2770277. doi: 10.1001/jama.2020.17021.
    PubMed     Abstract available

  619. STERNE JAC, Murthy S, Diaz JV, Slutsky AS, et al
    Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
    JAMA. 2020 Sep 2. pii: 2770279. doi: 10.1001/jama.2020.17023.
    PubMed     Abstract available

  620. PRESCOTT HC, Rice TW
    Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic.
    JAMA. 2020 Sep 2. pii: 2770275. doi: 10.1001/jama.2020.16747.

  621. DEQUIN PF, Heming N, Meziani F, Plantefeve G, et al
    Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Sep 2. pii: 2770276. doi: 10.1001/jama.2020.16761.
    PubMed     Abstract available

  622. GOSTIN LO, Cohen IG, Koplan JP
    Universal Masking in the United States: The Role of Mandates, Health Education, and the CDC.
    JAMA. 2020;324:837-838.

    August 2020
  623. AVORN J, Kesselheim A
    Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency.
    JAMA. 2020 Aug 31. pii: 2770244. doi: 10.1001/jama.2020.17101.

  624. THOMSON K, Nachlis H
    Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    JAMA. 2020 Aug 31. pii: 2770243. doi: 10.1001/jama.2020.16253.

  625. HEINTZMAN J, O'Malley J, Marino M, Todd JV, et al
    SARS-CoV-2 Testing and Changes in Primary Care Services in a Multistate Network of Community Health Centers During the COVID-19 Pandemic.
    JAMA. 2020 Aug 31. pii: 2770242. doi: 10.1001/jama.2020.15891.

  626. LUCEY CR, Johnston SC
    The Transformational Effects of COVID-19 on Medical Education.
    JAMA. 2020 Aug 26. pii: 2770075. doi: 10.1001/jama.2020.14136.

  627. RUBIN R
    From Auto Mechanic to Emergency Medicine Resident: Inspiring Young Blacks to Become Physicians.
    JAMA. 2020;324:727-729.

  628. WU Z, Wang Q, Zhao J, Yang P, et al
    Time Course of a Second Outbreak of COVID-19 in Beijing, China, June-July 2020.
    JAMA. 2020 Aug 24. pii: 2769930. doi: 10.1001/jama.2020.15894.

  629. SPINNER CD, Gottlieb RL, Criner GJ, Arribas Lopez JR, et al
    Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Aug 21. pii: 2769871. doi: 10.1001/jama.2020.16349.
    PubMed     Abstract available

  630. CHAMBERS C, Krogstad P, Bertrand K, Contreras D, et al
    Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women.
    JAMA. 2020 Aug 19. pii: 2769825. doi: 10.1001/jama.2020.15580.

  631. WANG EA, Zenilman J, Brinkley-Rubinstein L
    Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
    JAMA. 2020 Aug 17. pii: 2769694. doi: 10.1001/jama.2020.15589.

  632. BHASKAR ME, Arun S
    SARS-CoV-2 Infection Among Community Health Workers in India Before and After Use of Face Shields.
    JAMA. 2020 Aug 17. pii: 2769693. doi: 10.1001/jama.2020.15586.

  633. REALE SC, Fields KG, Lumbreras-Marquez MI, King CH, et al
    Association Between Number of In-Person Health Care Visits and SARS-CoV-2 Infection in Obstetrical Patients.
    JAMA. 2020 Aug 14. pii: 2769678. doi: 10.1001/jama.2020.15242.

    Researchers Strive to Recruit Hard-Hit Minorities Into COVID-19 Vaccine Trials.
    JAMA. 2020 Aug 13. pii: 2769611. doi: 10.1001/jama.2020.11244.

    An Inactivated Virus Candidate Vaccine to Prevent COVID-19.
    JAMA. 2020 Aug 13. pii: 2769609. doi: 10.1001/jama.2020.15539.

  636. XIA S, Duan K, Zhang Y, Zhao D, et al
    Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    JAMA. 2020 Aug 13. pii: 2769612. doi: 10.1001/jama.2020.15543.
    PubMed     Abstract available

  637. VAHIDY FS, Drews AL, Masud FN, Schwartz RL, et al
    Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area.
    JAMA. 2020 Aug 13. pii: 2769610. doi: 10.1001/jama.2020.15301.

  638. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response.
    JAMA. 2020 Aug 10. pii: 2769439. doi: 10.1001/jama.2020.14033.

  639. PARIKH S, O'Laughlin K, Ehrlich HY, Campbell L, et al
    Point Prevalence Testing of Residents for SARS-CoV-2 in a Subset of Connecticut Nursing Homes.
    JAMA. 2020 Aug 10. pii: 2769438. doi: 10.1001/jama.2020.14984.

  640. FIGUEROA JF, Wadhera RK, Papanicolas I, Riley K, et al
    Association of Nursing Home Ratings on Health Inspections, Quality of Care, and Nurse Staffing With COVID-19 Cases.
    JAMA. 2020 Aug 10. pii: 2769437. doi: 10.1001/jama.2020.14709.

  641. SHAH A, Marks PW, Hahn SM
    Unwavering Regulatory Safeguards for COVID-19 Vaccines.
    JAMA. 2020 Aug 7. pii: 2769421. doi: 10.1001/jama.2020.15725.

  642. MOSCOLA J, Sembajwe G, Jarrett M, Farber B, et al
    Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.
    JAMA. 2020 Aug 6. pii: 2769322. doi: 10.1001/jama.2020.14765.

  643. PRESCOTT HC, Girard TD
    Recovery From Severe COVID-19: Leveraging the Lessons of Survival From Sepsis.
    JAMA. 2020 Aug 5. pii: 2769290. doi: 10.1001/jama.2020.14103.

  644. MELLO MM, Greene JA, Sharfstein JM
    Attacks on Public Health Officials During COVID-19.
    JAMA. 2020 Aug 5. pii: 2769291. doi: 10.1001/jama.2020.14423.

  645. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA. 2020 Aug 5. pii: 2769289. doi: 10.1001/jama.2020.15067.

  646. ZYLKE JW, Bauchner H
    Mortality and Morbidity: The Measure of a Pandemic.
    JAMA. 2020;324:458-459.

  647. BAUCHNER H, Fontanarosa PB, Golub RM
    Editorial Evaluation and Peer Review During a Pandemic: How Journals Maintain Standards.
    JAMA. 2020;324:453-454.

    July 2020
    Women Physicians and the COVID-19 Pandemic.
    JAMA. 2020 Jul 31. pii: 2769140. doi: 10.1001/jama.2020.14797.

  649. STAUFFER WM, Alpern JD, Walker PF
    COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection.
    JAMA. 2020 Jul 30. pii: 2769100. doi: 10.1001/jama.2020.13170.

  650. DIBNER KA, Schweingruber HA, Christakis DA
    Reopening K-12 Schools During the COVID-19 Pandemic: A Report From the National Academies of Sciences, Engineering, and Medicine.
    JAMA. 2020 Jul 29. pii: 2769036. doi: 10.1001/jama.2020.14745.

  651. AUGER KA, Shah SS, Richardson T, Hartley D, et al
    Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US.
    JAMA. 2020 Jul 29. pii: 2769034. doi: 10.1001/jama.2020.14348.
    PubMed     Abstract available

  652. SARPATWARI A, Kaltenboeck A, Kesselheim AS
    Missed Opportunities on Emergency Remdesivir Use.
    JAMA. 2020;324:331-332.

  653. MCCORMACK G, Avery C, Spitzer AK, Chandra A, et al
    Economic Vulnerability of Households With Essential Workers.
    JAMA. 2020;324:388-390.

  654. RUBIN R
    COVID-19's Crushing Effects on Medical Practices, Some of Which Might Not Survive.
    JAMA. 2020;324:321-323.

  655. VAN DER MADE CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, et al
    Presence of Genetic Variants Among Young Men With Severe COVID-19.
    JAMA. 2020 Jul 24. pii: 2768926. doi: 10.1001/jama.2020.13719.
    PubMed     Abstract available

  656. KHOURY P, Azar E, Hitti E
    COVID-19 Response in Lebanon: Current Experience and Challenges in a Low-Resource Setting.
    JAMA. 2020 Jul 23. pii: 2768892. doi: 10.1001/jama.2020.12695.

  657. WALKER D
    The Work of Philanthropy in Responding to COVID-19 and Addressing Inequality: A New Foundation.
    JAMA. 2020 Jul 23. pii: 2768893. doi: 10.1001/jama.2020.12904.

  658. PETKOVA E, Antman EM, Troxel AB
    Pooling Data From Individual Clinical Trials in the COVID-19 Era.
    JAMA. 2020 Jul 22. pii: 2768851. doi: 10.1001/jama.2020.13042.

  659. LEE GM, Bell BP, Romero JR
    The Advisory Committee on Immunization Practices and Its Role in the Pandemic Vaccine Response.
    JAMA. 2020 Jul 22. pii: 2768852. doi: 10.1001/jama.2020.13167.

  660. MARKS PW, Hahn S
    Identifying the Risks of Unproven Regenerative Medicine Therapies.
    JAMA. 2020;324:241-242.

  661. KAMRATH C, Monkemoller K, Biester T, Rohrer TR, et al
    Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany.
    JAMA. 2020 Jul 20. pii: 2768716. doi: 10.1001/jama.2020.13445.

  662. BILALOGLU S, Aphinyanaphongs Y, Jones S, Iturrate E, et al
    Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.
    JAMA. 2020 Jul 20. pii: 2768715. doi: 10.1001/jama.2020.13372.

  663. FURUKAWA Y, Kansaku R
    Amabie-A Japanese Symbol of the COVID-19 Pandemic.
    JAMA. 2020 Jul 17. pii: 2768645. doi: 10.1001/jama.2020.12660.

  664. ABBASI J
    Social Isolation-the Other COVID-19 Threat in Nursing Homes.
    JAMA. 2020 Jul 16. pii: 2768640. doi: 10.1001/jama.2020.13484.

  665. SERAFEIM G, Rischbieth AM, Koh HK
    Sustainability, Business, and Health.
    JAMA. 2020;324:147-148.

    "Are You Wearing Your White Coat?": Telemedicine in the Time of Pandemic.
    JAMA. 2020;324:149-150.

  667. HUYNH PP, Ishii LE, Ishii M
    What Is Anosmia?
    JAMA. 2020;324:206.

  668. SHARFSTEIN JM, Morphew CC
    The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020.
    JAMA. 2020;324:133-134.

  669. BROOKS JT, Butler JC, Redfield RR
    Universal Masking to Prevent SARS-CoV-2 Transmission-The Time Is Now.
    JAMA. 2020 Jul 14. pii: 2768532. doi: 10.1001/jama.2020.13107.

  670. WANG X, Ferro EG, Zhou G, Hashimoto D, et al
    Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers.
    JAMA. 2020 Jul 14. pii: 2768533. doi: 10.1001/jama.2020.12897.

  671. WIERSINGA WJ, Prescott HC
    What Is COVID-19?
    JAMA. 2020 Jul 10. pii: 2768390. doi: 10.1001/jama.2020.12984.

  672. WIERSINGA WJ, Rhodes A, Cheng AC, Peacock SJ, et al
    Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA. 2020 Jul 10. pii: 2768391. doi: 10.1001/jama.2020.12839.
    PubMed     Abstract available

  673. CARFI A, Bernabei R, Landi F
    Persistent Symptoms in Patients After Acute COVID-19.
    JAMA. 2020 Jul 9. pii: 2768351. doi: 10.1001/jama.2020.12603.

  674. RUBIN R
    School Superintendents Confront COVID-19-"There Are No Good Options for Next Year".
    JAMA. 2020 Jul 9. pii: 2768352. doi: 10.1001/jama.2020.12575.

    Challenges Estimating Total Lives Lost in COVID-19 Decisions: Consideration of Mortality Related to Unemployment, Social Isolation, and Depression.
    JAMA. 2020 Jul 8. pii: 2768250. doi: 10.1001/jama.2020.12187.

  676. SALONER B, Parish K, Ward JA, DiLaura G, et al
    COVID-19 Cases and Deaths in Federal and State Prisons.
    JAMA. 2020 Jul 8. pii: 2768249. doi: 10.1001/jama.2020.12528.

  677. DEGESYS NF, Wang RC, Kwan E, Fahimi J, et al
    Correlation Between N95 Extended Use and Reuse and Fit Failure in an Emergency Department.
    JAMA. 2020;324:94-96.

  678. MCGINTY EE, Presskreischer R, Han H, Barry CL, et al
    Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020.
    JAMA. 2020;324:93-94.

  679. USCHER-PINES L, Huskamp HA, Mehrotra A
    Treating Patients With Opioid Use Disorder in Their Homes: An Emerging Treatment Model.
    JAMA. 2020;324:39-40.

  680. O'CALLAGHAN KP, Blatz AM, Offit PA
    Developing a SARS-CoV-2 Vaccine at Warp Speed.
    JAMA. 2020 Jul 6. pii: 2768155. doi: 10.1001/jama.2020.12190.

  681. WOOLF SH, Chapman DA, Sabo RT, Weinberger DM, et al
    Excess Deaths From COVID-19 and Other Causes, March-April 2020.
    JAMA. 2020 Jul 1. pii: 2768086. doi: 10.1001/jama.2020.11787.

    June 2020
    A Cruel COVID-19 Irony.
    JAMA. 2020 Jun 30. pii: 2767995. doi: 10.1001/jama.2020.11882.

  683. HALPERN SD, Truog RD, Miller FG
    Cognitive Bias and Public Health Policy During the COVID-19 Pandemic.
    JAMA. 2020 Jun 29. pii: 2767950. doi: 10.1001/jama.2020.11623.

  684. ABBASI J
    Taking a Closer Look at COVID-19, Health Inequities, and Racism.
    JAMA. 2020 Jun 29. pii: 2767948. doi: 10.1001/jama.2020.11672.

    Rereading Arrowsmith in the COVID-19 Pandemic.
    JAMA. 2020 Jun 26. pii: 2767891. doi: 10.1001/jama.2020.11489.

  686. AUSTIN JM, Kachalia A
    The State of Health Care Quality Measurement in the Era of COVID-19: The Importance of Doing Better.
    JAMA. 2020 Jun 25. pii: 2767747. doi: 10.1001/jama.2020.11461.

  687. BARNETT ML, Hu L, Martin T, Grabowski DC, et al
    Mortality, Admissions, and Patient Census at SNFs in 3 US Cities During the COVID-19 Pandemic.
    JAMA. 2020 Jun 24. pii: 2767750. doi: 10.1001/jama.2020.11642.

  688. WHITE DB, Angus DC
    A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
    JAMA. 2020 Jun 24. pii: 2767751. doi: 10.1001/jama.2020.11464.

  689. DESAI AN
    Artificial Intelligence: Promise, Pitfalls, and Perspective.
    JAMA. 2020;323:2448-2449.

  690. SONG Z
    Potential Implications of Lowering the Medicare Eligibility Age to 60.
    JAMA. 2020;323:2472-2473.

  691. TOLLES J, Luong T
    Modeling Epidemics With Compartmental Models.
    JAMA. 2020;323:2515-2516.

  692. VOLPP KG, Diamond SM, Shrank WH
    Innovation in Home Care: Time for a New Payment Model.
    JAMA. 2020;323:2474-2475.

  693. MARTINEZ DA, Hinson JS, Klein EY, Irvin NA, et al
    SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region.
    JAMA. 2020 Jun 18. pii: 2767632. doi: 10.1001/jama.2020.11374.

  694. EMERUWA UN, Ona S, Shaman JL, Turitz A, et al
    Associations Between Built Environment, Neighborhood Socioeconomic Status, and SARS-CoV-2 Infection Among Pregnant Women in New York City.
    JAMA. 2020 Jun 18. pii: 2767631. doi: 10.1001/jama.2020.11370.

  695. THOMAS LE, Li F, Pencina MJ
    Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial.
    JAMA. 2020;323:2417-2418.

  696. RODRIGUEZ JA, Clark CR, Bates DW
    Digital Health Equity as a Necessity in the 21st Century Cures Act Era.
    JAMA. 2020;323:2381-2382.

  697. BUNYAVANICH S, Do A, Vicencio A
    Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.
    JAMA. 2020;323:2427-2429.

  698. SHACHAR C, Engel J, Elwyn G
    Implications for Telehealth in a Postpandemic Future: Regulatory and Privacy Issues.
    JAMA. 2020;323:2375-2376.

  699. ISON MG, Wolfe C, Boucher HW
    Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    JAMA. 2020;323:2365-2366.

  700. MALANI AN, Sherbeck JP, Malani PN
    Convalescent Plasma and COVID-19.
    JAMA. 2020 Jun 12. pii: 2767351. doi: 10.1001/jama.2020.10699.

  701. ANTIEL RM
    Oedipus and the Coronavirus Pandemic.
    JAMA. 2020;323:2231-2232.

    Surgery in a Time of Uncertainty: A Need for Universal Respiratory Precautions in the Operating Room.
    JAMA. 2020;323:2254-2255.

  703. LI L, Zhang W, Hu Y, Tong X, et al
    Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Jun 3. pii: 2766943. doi: 10.1001/jama.2020.10044.
    PubMed     Abstract available

    Choices for the "New Normal".
    JAMA. 2020;323:2125-2126.

    May 2020
  705. VADUGANATHAN M, van Meijgaard J, Mehra MR, Joseph J, et al
    Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States.
    JAMA. 2020 May 28. pii: 2766773. doi: 10.1001/jama.2020.9184.

  706. SEN S, Karaca-Mandic P, Georgiou A
    Association of Stay-at-Home Orders With COVID-19 Hospitalizations in 4 States.
    JAMA. 2020 May 27. pii: 2766673. doi: 10.1001/jama.2020.9176.

  707. TROGEN B, Oshinsky D, Caplan A
    Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    JAMA. 2020 May 26. pii: 2766651. doi: 10.1001/jama.2020.8917.

  708. CAMPBELL KH, Tornatore JM, Lawrence KE, Illuzzi JL, et al
    Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut.
    JAMA. 2020 May 26. pii: 2766650. doi: 10.1001/jama.2020.8904.

  709. GLIED S, Levy H
    The Potential Effects of Coronavirus on National Health Expenditures.
    JAMA. 2020;323:2001-2002.

  710. BAUCHNER H, Easley TJ
    Health Care Heroes of the COVID-19 Pandemic.
    JAMA. 2020;323:2021.

  711. RUBIN R
    Finding Ways to Reduce Coronavirus Exposure During Dialysis.
    JAMA. 2020;323:1993-1995.

  712. SCHRAG D, Hershman DL, Basch E
    Oncology Practice During the COVID-19 Pandemic.
    JAMA. 2020;323:2005-2006.

  713. MERCHANT RM, Lurie N
    Social Media and Emergency Preparedness in Response to Novel Coronavirus.
    JAMA. 2020;323:2011-2012.

    Lost Space.
    JAMA. 2020;323:2019-2020.

  715. FELDMAN O, Meir M, Shavit D, Idelman R, et al
    Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment.
    JAMA. 2020;323:2091-2093.

  716. ARORA KS, Mauch JT, Gibson KS
    Labor and Delivery Visitor Policies During the COVID-19 Pandemic: Balancing Risks and Benefits.
    JAMA. 2020 May 22. pii: 2766598. doi: 10.1001/jama.2020.7563.

  717. DEL RIO C, Malani P
    Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
    JAMA. 2020 May 22. pii: 2766600. doi: 10.1001/jama.2020.9252.

  718. SCHALLER T, Hirschbuhl K, Burkhardt K, Braun G, et al
    Postmortem Examination of Patients With COVID-19.
    JAMA. 2020 May 21. pii: 2766557. doi: 10.1001/jama.2020.8907.

  719. WHITCROFT KL, Hummel T
    Olfactory Dysfunction in COVID-19: Diagnosis and Management.
    JAMA. 2020 May 20. pii: 2766523. doi: 10.1001/jama.2020.8391.

  720. ABBASI J
    Prioritizing Physician Mental Health as COVID-19 Marches On.
    JAMA. 2020 May 20. pii: 2766525. doi: 10.1001/jama.2020.5205.

  721. OWEN WF JR, Carmona R, Pomeroy C
    Failing Another National Stress Test on Health Disparities.
    JAMA. 2020;323:1905-1906.

  722. ANGUS DC
    Optimizing the Trade-off Between Learning and Doing in a Pandemic.
    JAMA. 2020;323:1895-1896.

  723. SCHAFFER DEROO S, Pudalov NJ, Fu LY
    Planning for a COVID-19 Vaccination Program.
    JAMA. 2020 May 18. pii: 2766370. doi: 10.1001/jama.2020.8711.

  724. COLLINS FS, Stoffels P
    Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times.
    JAMA. 2020 May 18. pii: 2766371. doi: 10.1001/jama.2020.8920.

  725. SARTINI C, Tresoldi M, Scarpellini P, Tettamanti A, et al
    Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit.
    JAMA. 2020 May 15. pii: 2766291. doi: 10.1001/jama.2020.7861.

  726. ANGULO FJ, Finelli L, Swerdlow DL
    Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level.
    JAMA. 2020 May 15. pii: 2766293. doi: 10.1001/jama.2020.7872.

  727. ELHARRAR X, Trigui Y, Dols AM, Touchon F, et al
    Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure.
    JAMA. 2020 May 15. pii: 2766292. doi: 10.1001/jama.2020.8255.

  728. RUBIN R
    Global Effort to Collect Data on Ventilated Patients With COVID-19.
    JAMA. 2020 May 13. pii: 2766183. doi: 10.1001/jama.2020.8341.

  729. HAMIEL U, Kozer E, Youngster I
    SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults.
    JAMA. 2020 May 13. pii: 2766182. doi: 10.1001/jama.2020.8189.

  730. ROSENBERG ES, Dufort EM, Udo T, Wilberschied LA, et al
    Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
    JAMA. 2020 May 11. pii: 2766117. doi: 10.1001/jama.2020.8630.
    PubMed     Abstract available

  731. WEBB HOOPER M, Napoles AM, Perez-Stable EJ
    COVID-19 and Racial/Ethnic Disparities.
    JAMA. 2020 May 11. pii: 2766098. doi: 10.1001/jama.2020.8598.

  732. KIRKCALDY RD, King BA, Brooks JT
    COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
    JAMA. 2020 May 11. pii: 2766097. doi: 10.1001/jama.2020.7869.

  733. RANDHAWA AK, Fisher LH, Greninger AL, Li SS, et al
    Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1-April 16, 2020.
    JAMA. 2020 May 8. pii: 2766035. doi: 10.1001/jama.2020.8097.

  734. BOLLYKY TJ, Gostin LO, Hamburg MA
    The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
    JAMA. 2020 May 7. pii: 2765944. doi: 10.1001/jama.2020.6641.

  735. SETHURAMAN N, Jeremiah SS, Ryo A
    Interpreting Diagnostic Tests for SARS-CoV-2.
    JAMA. 2020 May 6. pii: 2765837. doi: 10.1001/jama.2020.8259.

  736. HALL MA, Studdert DM
    Privileges and Immunity Certification During the COVID-19 Pandemic.
    JAMA. 2020 May 6. pii: 2765835. doi: 10.1001/jama.2020.7712.

  737. PERSAD G, Emanuel EJ
    The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    JAMA. 2020 May 6. pii: 2765836. doi: 10.1001/jama.2020.8102.

  738. BAUCHNER H, Fontanarosa PB
    Randomized Clinical Trials and COVID-19: Managing Expectations.
    JAMA. 2020 May 4. pii: 2765696. doi: 10.1001/jama.2020.8115.

  739. CUTLER DM, Nikpay S, Huckman RS
    The Business of Medicine in the Era of COVID-19.
    JAMA. 2020 May 1. pii: 2765668. doi: 10.1001/jama.2020.7242.

    April 2020
  740. PERENCEVICH EN, Diekema DJ, Edmond MB
    Moving Personal Protective Equipment Into the Community: Face Shields and Containment of COVID-19.
    JAMA. 2020 Apr 29. pii: 2765525. doi: 10.1001/jama.2020.7477.

  741. MARINI JJ, Gattinoni L
    Management of COVID-19 Respiratory Distress.
    JAMA. 2020 Apr 24. pii: 2765302. doi: 10.1001/jama.2020.6825.

  742. SPINATO G, Fabbris C, Polesel J, Cazzador D, et al
    Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.
    JAMA. 2020 Apr 22. pii: 2765183. doi: 10.1001/jama.2020.6771.

  743. RICHARDSON S, Hirsch JS, Narasimhan M, Crawford JM, et al
    Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
    JAMA. 2020 Apr 22. pii: 2765184. doi: 10.1001/jama.2020.6775.
    PubMed     Abstract available

  744. CHOW EJ, Schwartz NG, Tobolowsky FA, Zacks RLT, et al
    Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington.
    JAMA. 2020 Apr 17. pii: 2764953. doi: 10.1001/jama.2020.6637.

  745. DESAI AN, Aronoff DM
    Masks and Coronavirus Disease 2019 (COVID-19).
    JAMA. 2020 Apr 17. pii: 2764955. doi: 10.1001/jama.2020.6437.

  746. KIM D, Quinn J, Pinsky B, Shah NH, et al
    Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.
    JAMA. 2020 Apr 15. pii: 2764787. doi: 10.1001/jama.2020.6266.

    March 2020
  747. GRABOWSKI DC, Joynt Maddox KE
    Postacute Care Preparedness for COVID-19: Thinking Ahead.
    JAMA. 2020 Mar 25. pii: 2763818. doi: 10.1001/jama.2020.4686.

  748. BACHIREDDY C, Chen C, Dar M
    Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid's Response to COVID-19.
    JAMA. 2020 Mar 19. pii: 2763487. doi: 10.1001/jama.2020.4272.

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.